Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Head and Neck Cancer

  Free Subscription


Articles published in Head Neck

Retrieve available abstracts of 581 articles:
HTML format



Single Articles


    July 2022
  1. JONES AJ, Davis KP, Novinger LJ, Bonetto A, et al
    Postoperative consequences of cancer cachexia after head and neck free flap reconstruction.
    Head Neck. 2022;44:1665-1677.
    PubMed     Abstract available


  2. HELMERS R, Milstein DMJ, Straat NF, Navran A, et al
    The impact of hyperbaric oxygen therapy on late irradiation injury in oral microcirculation.
    Head Neck. 2022;44:1646-1654.
    PubMed     Abstract available


  3. WADHAVKAR N, Jorgensen JB, Bollig CA
    Association of comorbidity score with perioperative outcomes following transoral robotic surgery: National analysis.
    Head Neck. 2022;44:1655-1664.
    PubMed     Abstract available


  4. DONG W, Horiuchi K, Noguchi E, Okamoto T, et al
    Predictive value of metastatic lateral lymph node ratio for recurrence in pathologically lateral lymph node-positive papillary thyroid cancer patients with palpable lymph nodes.
    Head Neck. 2022;44:1623-1630.
    PubMed     Abstract available


  5. WANG R, Horwich P, Sandulache VC, Hernandez DJ, et al
    Safety of microvascular free tissue transfer reconstruction of the head and neck in the setting of chronic pharmacologic immunosuppression.
    Head Neck. 2022;44:1520-1527.
    PubMed     Abstract available


  6. FROEHLICH MH, Shih MC, Shehee L, Kompelli AR, et al
    Systematic review of neuroendocrine carcinomas of the oropharynx.
    Head Neck. 2022;44:1725-1736.
    PubMed     Abstract available


  7. MATOS LL, Capuzzo RC, Pedruzzi PAG, Farias T, et al
    Sentinel lymph node biopsy for early squamous cell carcinoma of the lip and oral cavity: Real-world experience in Brazil.
    Head Neck. 2022;44:1604-1615.
    PubMed     Abstract available


  8. SWIECICKI PL, Bellile E, Casper K, Chinn SB, et al
    Randomized trial of laryngeal organ preservation evaluating two cycles of induction chemotherapy with platinum, docetaxel, and a novel Bcl-xL inhibitor.
    Head Neck. 2022;44:1509-1519.
    PubMed     Abstract available


  9. KIMURA S, Noguchi H, Yoshida K, Sato H, et al
    Relationship of histamine expression with chemokine balance in the tumor microenvironment of squamous cell carcinoma of the tongue.
    Head Neck. 2022;44:1554-1562.
    PubMed     Abstract available


  10. SEO GT, Wein LE, Dowling EM, Khorsandi AS, et al
    A novel technique for management of stenosis of the postlaryngectomy stoma with preservation of a functional tracheoesophageal puncture following tracheal resection.
    Head Neck. 2022;44:1737-1741.
    PubMed     Abstract available


  11. SUAREZ AJURIA M, Gallas Torreira M, Garcia Garcia A, Marichalar Mendia X, et al
    Efficacy of different sentinel lymph node biopsy protocols in oral squamous cell carcinoma: Systematic review and meta-analysis.
    Head Neck. 2022;44:1702-1714.
    PubMed     Abstract available


  12. DE CARVALHO KIMURA T, Henschel FAN, Carneiro MC, Santin GC, et al
    Oral metastasis as the first indication of undiscovered malignancy at a distant site: A systematic review of 413 cases.
    Head Neck. 2022;44:1715-1724.
    PubMed     Abstract available


    June 2022
  13. HO CM, Chen YH, Hsu WH, Wang WY, et al
    Comparative effectiveness and stage-shift effect of endoscopic exam among newly diagnosed oral cancer patients with different stages in Taiwan.
    Head Neck. 2022 Jun 25. doi: 10.1002/hed.27123.
    PubMed     Abstract available


  14. AL-QURAYSHI Z, Sullivan CB, Allison DB, Buchakjian MR, et al
    Presentation and outcomes of patients with clinically T1-2, N0 parotid mucoepidermoid carcinoma: The roles of elective neck dissection and adjuvant radiotherapy.
    Head Neck. 2022 Jun 22. doi: 10.1002/hed.27128.
    PubMed     Abstract available


  15. DAI Y, Wang Z, Yan E, Li J, et al
    Development of a novel signature derived from single cell RNA-sequencing for preoperative prediction of lymph node metastasis in head and neck squamous cell carcinoma.
    Head Neck. 2022 Jun 21. doi: 10.1002/hed.27126.
    PubMed     Abstract available


  16. SHAO YF, Kim S, Cramer JD, Farhat D, et al
    African American race as a risk factor associated with a second primary lung cancer after initial primary head and neck cancer.
    Head Neck. 2022 Jun 17. doi: 10.1002/hed.27107.
    PubMed     Abstract available


  17. COSTANTINO A, Canali L, Festa BM, Spriano G, et al
    Sentinel lymph node biopsy in high-risk cutaneous squamous cell carcinoma of the head and neck: Systematic review and meta-analysis.
    Head Neck. 2022 Jun 17. doi: 10.1002/hed.27121.
    PubMed     Abstract available


  18. DENISSOFF A, Huusko T, Ventela S, Niemela S, et al
    Exposure to alcohol and overall survival in head and neck cancer: A regional cohort study.
    Head Neck. 2022 Jun 17. doi: 10.1002/hed.27125.
    PubMed     Abstract available


  19. YANG A, Tanamal P, Tibbetts K, Sumer B, et al
    Characteristics and outcomes of young patients with laryngeal cancer: National hospital-based retrospective cohort analysis.
    Head Neck. 2022 Jun 16. doi: 10.1002/hed.27120.
    PubMed     Abstract available


  20. SCHAR MS, Omari TI, Woods CM, Footner LR, et al
    Pharyngeal tongue base augmentation for dysphagia therapy: A prospective case series in patients post head and neck cancer treatment.
    Head Neck. 2022 Jun 4. doi: 10.1002/hed.27104.
    PubMed     Abstract available


  21. CHARGI N, Breik O, Forouzanfar T, Martin T, et al
    Association of low skeletal muscle mass and systemic inflammation with surgical complications and survival after microvascular flap reconstruction in patients with head and neck cancer.
    Head Neck. 2022 Jun 2. doi: 10.1002/hed.27113.
    PubMed     Abstract available


  22. NASSIF SJ, Sasani AR, Faller GT, Harb JL, et al
    Milan system for reporting salivary gland cytopathology: Adoption and outcomes in a community setting.
    Head Neck. 2022;44:1462-1467.
    PubMed     Abstract available


  23. ABU-SHAMA Y, Renard S, Nguyen DT, Henrot P, et al
    Descriptive analysis of recurrences of nasal intestinal-type adenocarcinomas after radiotherapy.
    Head Neck. 2022;44:1356-1367.
    PubMed     Abstract available


  24. KUSAFUKA K, Sato Y, Nakatani E, Baba S, et al
    The implicated clinical factors for outcomes in 304 patients with salivary duct carcinoma: Multi-institutional retrospective analysis in Japan.
    Head Neck. 2022;44:1430-1441.
    PubMed     Abstract available


  25. PAIK C, Osterbauer B, Sahyouni G, Park S, et al
    Thyroid tumor ratio: Improving the assessment of the impact of size in pediatric thyroid cancer.
    Head Neck. 2022;44:1342-1348.
    PubMed     Abstract available


  26. BLASCO MA, Noel CW, Truong T, Huang SH, et al
    Radiologic-pathologic correlation of major versus minor extranodal extension in oral cavity cancer.
    Head Neck. 2022;44:1422-1429.
    PubMed     Abstract available


  27. KATZ AP, Larkin R, Cohen ER, Franzmann E, et al
    Indications and outcomes for elective dissection of level V in primary parotid cancer.
    Head Neck. 2022;44:1349-1355.
    PubMed     Abstract available


  28. SHONKA DC JR, Ho A, Chintakuntlawar AV, Geiger JL, et al
    American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatment.
    Head Neck. 2022;44:1277-1300.
    PubMed     Abstract available


  29. ELSERAGY A, Bello IO, Wahab A, Coletta RD, et al
    Emerging histopathologic markers in early-stage oral tongue cancer: A systematic review and meta-analysis.
    Head Neck. 2022;44:1481-1491.
    PubMed     Abstract available


  30. TSANG RK, Chan WCP, Holsinger FC, Chung JCK, et al
    Long-term results of robotic-assisted nasopharyngectomy for recurrent nasopharyngeal carcinoma.
    Head Neck. 2022 Jun 1. doi: 10.1002/hed.27115.
    PubMed     Abstract available


    May 2022
  31. KOKSAL M, Saur L, Scafa D, Sarria G, et al
    Late toxicity-related symptoms and fraction dose affect decision regret among patients receiving adjuvant radiotherapy for head and neck cancer.
    Head Neck. 2022 May 30. doi: 10.1002/hed.27103.
    PubMed     Abstract available


  32. LEE J, Lee JJB, Cha IH, Park KR, et al
    Risk factor analysis of dental implants in patients with irradiated head and neck cancer.
    Head Neck. 2022 May 12. doi: 10.1002/hed.27080.
    PubMed     Abstract available


  33. DESHMUKH J, Chatterjee A, Dora TK, Bose S, et al
    Recurrence pattern with respect to two different dose fractionations in patients with locally advanced head and neck cancer treated with chemoradiation using image-guided volumetric arc therapy.
    Head Neck. 2022 May 10. doi: 10.1002/hed.27075.
    PubMed     Abstract available


  34. KUTUK T, McAllister NC, Rzepczynski AE, Williams A, et al
    Submandibular gland transfer for the prevention of radiation-induced xerostomia in oropharyngeal cancer: Dosimetric impact in the intensity modulated radiotherapy era.
    Head Neck. 2022;44:1213-1222.
    PubMed     Abstract available


  35. PETRELLI F, Luciani A, Ghidini A, Cherri S, et al
    Treatment de-escalation for HPV+ oropharyngeal cancer: A systematic review and meta-analysis.
    Head Neck. 2022;44:1255-1266.
    PubMed     Abstract available


  36. MULLER RG, Weidenbecher M, Ludlow D
    PET/CT versus triple endoscopy in initial workup of HPV+ oropharyngeal squamous cell carcinoma.
    Head Neck. 2022;44:1164-1171.
    PubMed     Abstract available


  37. ZHAO L, Day AT, Moon D, Avkshtol V, et al
    Survival and disease progression following solitary locoregional recurrence after head and neck radiotherapy.
    Head Neck. 2022;44:1153-1163.
    PubMed     Abstract available


  38. PEETERS F, Van Dessel J, Croonenborghs TM, Smeets M, et al
    Value of six comorbidity scales for predicting survival of patients with primary surgery for oral squamous cell carcinoma.
    Head Neck. 2022;44:1142-1152.
    PubMed     Abstract available


  39. OOMS M, Ponke L, Puladi B, Winnand P, et al
    Impact of secondary tumor-free resection margins in soft tissue on local, regional, and distant recurrence in R0-resected oral squamous cell carcinoma.
    Head Neck. 2022;44:1172-1181.
    PubMed     Abstract available


  40. STEPAN K, Craig E, Skillington SA, Deutsch BC, et al
    Development of second primary malignancies after transoral surgery in human papilloma virus-positive oropharyngeal squamous cell carcinoma.
    Head Neck. 2022;44:1069-1078.
    PubMed     Abstract available


  41. STEVENS MN, Gallant JN, Feldman MJ, Sermarini AJ, et al
    Management of postradiation late hemorrhage following treatment for HPV-positive oropharyngeal squamous cell carcinoma.
    Head Neck. 2022;44:1079-1085.
    PubMed     Abstract available


    April 2022
  42. FORMAN R, Deshpande H, Burtness B, Bhatia AK, et al
    Efficacy and toxicity of weekly paclitaxel, carboplatin, and cetuximab as induction chemotherapy or in cases of metastases or relapse for head and neck cancer with a focus on elderly or frail patients.
    Head Neck. 2022 Apr 30. doi: 10.1002/hed.27077.
    PubMed     Abstract available


  43. KOBAYASHI K, Ikeda A, Matsumoto Y, Matsumura S, et al
    Surgical technique for superselective neck dissection under local anesthesia in recurrent head and neck cancer.
    Head Neck. 2022 Apr 26. doi: 10.1002/hed.27071.
    PubMed     Abstract available


  44. LI D, Li X, Fan G, Bian G, et al
    Identification of the regulatory role of the circ_0004788/miR-515-5p/FGF2 network in nasopharyngeal carcinoma development.
    Head Neck. 2022 Apr 23. doi: 10.1002/hed.27066.
    PubMed     Abstract available


  45. EARNEST-NOBLE LB, Lipsky RS, Kuhel WI, Kutler DI, et al
    Identification of occult metastatic disease via lymphoscintigraphy-guided neck dissection in N0 oral squamous cell carcinoma.
    Head Neck. 2022 Apr 16. doi: 10.1002/hed.27059.
    PubMed     Abstract available


  46. MUKHERJEE A, Wiener HW, Griffin RL, Lenneman C, et al
    Racial and rural-urban disparities in cardiovascular risk factors among patients with head and neck cancer in a clinical cohort.
    Head Neck. 2022 Apr 9. doi: 10.1002/hed.27054.
    PubMed     Abstract available


  47. ZHANG W, Li L, Guo E, Zhou H, et al
    Inhibition of PDK1 enhances radiosensitivity and reverses epithelial-mesenchymal transition in nasopharyngeal carcinoma.
    Head Neck. 2022 Apr 8. doi: 10.1002/hed.27053.
    PubMed     Abstract available


  48. KORPICS MC, Turchan WT, Koshy M, Spiotto MT, et al
    Decreased overall survival in patients with locally advanced head and neck cancer receiving definitive radiotherapy and concurrent cetuximab: National Cancer Database analysis.
    Head Neck. 2022 Apr 7. doi: 10.1002/hed.27050.
    PubMed     Abstract available


  49. MAO M, Qiu K, Ren J, Zhao Y, et al
    The revised Pittsburgh staging system for middle ear squamous cell carcinoma: A challenging clinical dilemma.
    Head Neck. 2022 Apr 5. doi: 10.1002/hed.27047.
    PubMed    


  50. JIN YN, Liu BQ, Peng KW, Ou XQ, et al
    The prognostic value of adding systemic inflammation response index to Epstein-Barr virus DNA in childhood nasopharyngeal carcinoma: A real-world study.
    Head Neck. 2022 Apr 4. doi: 10.1002/hed.27033.
    PubMed     Abstract available


  51. BIRKENBEUEL JL, Pang JC, Lee A, Nguyen ES, et al
    Long-term outcomes in sinonasal squamous cell carcinoma arising from inverted papilloma: Systematic review.
    Head Neck. 2022;44:1014-1029.
    PubMed     Abstract available


  52. LEE HI, Kim JH, Lee JH, Wu HG, et al
    Reducing target volume in definitive radiotherapy for human papillomavirus-associated tonsil cancer.
    Head Neck. 2022;44:989-997.
    PubMed     Abstract available


  53. OLIVER JR, Karadaghy OA, Fassas SN, Arambula Z, et al
    Machine learning directed sentinel lymph node biopsy in cutaneous head and neck melanoma.
    Head Neck. 2022;44:975-988.
    PubMed     Abstract available


  54. ESSAT M, Cooper K, Bessey A, Clowes M, et al
    Diagnostic accuracy of conventional oral examination for detecting oral cavity cancer and potentially malignant disorders in patients with clinically evident oral lesions: Systematic review and meta-analysis.
    Head Neck. 2022;44:998-1013.
    PubMed     Abstract available


  55. AGGARWAL P, Hutcheson KA, Goepfert RP, Garden AS, et al
    Risk factors associated with patient-reported fatigue among long-term oropharyngeal carcinoma survivors.
    Head Neck. 2022;44:952-963.
    PubMed     Abstract available


  56. ADILBAY D, Valero C, Fitzgerald C, Yuan A, et al
    Outcomes in surgical management of sinonasal malignancy-A single comprehensive cancer center experience.
    Head Neck. 2022;44:933-942.
    PubMed     Abstract available


  57. VUONG HG, Le MK, Hassell L, Kondo T, et al
    The differences in distant metastatic patterns and their corresponding survival between thyroid cancer subtypes.
    Head Neck. 2022;44:926-932.
    PubMed     Abstract available


  58. BEUTE JE, Seo GT, Greenberg LA, Mundi N, et al
    Cuneiform (cuniculatum) variant of oral squamous cell carcinoma revisited: Presentation of two cases and literature review of a rare entity.
    Head Neck. 2022;44:E16-E24.
    PubMed     Abstract available


  59. YANG B, Eliot M, McClean MD, Waterboer T, et al
    DNA methylation-derived systemic inflammation indices and their association with oropharyngeal cancer risk and survival.
    Head Neck. 2022;44:904-913.
    PubMed     Abstract available


  60. PARK YM, Lim JY, Koh YW, Kim SH, et al
    Machine learning and magnetic resonance imaging radiomics for predicting human papilloma virus status and prognostic factors in oropharyngeal squamous cell carcinoma.
    Head Neck. 2022;44:897-903.
    PubMed     Abstract available


  61. WU SS, Chen B, Fleming CW, Shah AA, et al
    Nasopharyngeal cancer: Incidence and prognosis of human papillomavirus and Epstein-Barr virus association at a single North American institution.
    Head Neck. 2022;44:851-861.
    PubMed     Abstract available


  62. FERRARI M, Zanoletti E, Taboni S, Cazzador D, et al
    Resection of the internal carotid artery in selected patients affected by cancer of the skull base.
    Head Neck. 2022;44:1030-1042.
    PubMed     Abstract available


  63. BOLLIG CA, Morris B, Stubbs VC
    Transoral robotic surgery with neck dissection versus nonsurgical treatment in stage I and II human papillomavirus-negative oropharyngeal cancer.
    Head Neck. 2022 Apr 1. doi: 10.1002/hed.27045.
    PubMed     Abstract available


  64. TWU CW, Lin PJ, Tsou HH, Liu YC, et al
    Maintenance metronomic chemotherapy for metastatic/recurrent nasopharyngeal carcinoma.
    Head Neck. 2022 Apr 1. doi: 10.1002/hed.27044.
    PubMed     Abstract available


    March 2022
  65. ARBAB M, Chen YH, Tishler RB, Gunasti L, et al
    Association between radiation dose to organs at risk and acute patient reported outcome during radiation treatment for head and neck cancers.
    Head Neck. 2022 Mar 31. doi: 10.1002/hed.27031.
    PubMed     Abstract available


  66. GETZ KR, Bellile E, Zarins KR, Chinn SB, et al
    The association between inflammatory biomarkers and statin use among patients with head and neck squamous cell carcinoma.
    Head Neck. 2022 Mar 25. doi: 10.1002/hed.27040.
    PubMed     Abstract available


  67. FOLEY J, Burns CL, Ward EC, Nund RL, et al
    Post-acute health care needs of people with head and neck cancer: Mapping health care services, experiences, and the impact of rurality.
    Head Neck. 2022 Mar 23. doi: 10.1002/hed.27037.
    PubMed     Abstract available


  68. GILLEY DR, Clark AD, Wieser ME, Bollig CA, et al
    Effectiveness of gabapentin in reducing opioid requirements after radiation in head and neck cancer in a single institution.
    Head Neck. 2022 Mar 22. doi: 10.1002/hed.27035.
    PubMed     Abstract available


  69. ZENGA J, Awan MJ, Frei A, Petrie E, et al
    Chronic stress promotes an immunologic inflammatory state and head and neck cancer growth in a humanized murine model.
    Head Neck. 2022 Mar 8. doi: 10.1002/hed.27028.
    PubMed     Abstract available


  70. AL-QURAYSHI Z, Ngouajio AL, Buchakjian MR
    Presentation and outcomes of patients with clinically T1-2, N0 supraglottic squamous cell carcinoma: The role of definitive radiotherapy compared to primary partial laryngectomy.
    Head Neck. 2022;44:735-744.
    PubMed     Abstract available


  71. JANIK S, Faisal M, Marijic B, Grasl S, et al
    Prognostic factors in mammary analogue secretory carcinomas of the parotid gland: Systematic review and meta-analysis.
    Head Neck. 2022;44:792-804.
    PubMed     Abstract available


  72. KINBERG EC, Garneau JC, Eljazzar R, Genden EM, et al
    Postparotidectomy sialocele: 6-year review of underlying factors.
    Head Neck. 2022;44:745-748.
    PubMed     Abstract available


  73. ORLOFF LA, Noel JE, Stack BC Jr, Russell MD, et al
    Radiofrequency ablation and related ultrasound-guided ablation technologies for treatment of benign and malignant thyroid disease: An international multidisciplinary consensus statement of the American Head and Neck Society Endocrine Surgery Section w
    Head Neck. 2022;44:633-660.
    PubMed     Abstract available


  74. DEANE EC, Liu AQ, Nguyen S, Anderson DW, et al
    Synchrony in head and neck surgery: Feasibility and outcomes of simultaneous scapular free flap reconstruction.
    Head Neck. 2022;44:760-769.
    PubMed     Abstract available


  75. FENLON JB, Hutten RJ, Weil CR, Lloyd S, et al
    Comparing adjuvant radiation to adjuvant chemoradiation in postsurgical p16+ oropharyngeal carcinoma patients with extranodal extension or positive margins.
    Head Neck. 2022;44:606-614.
    PubMed     Abstract available


  76. MAYLAND E, Curry JM, Wax MK, Thomas CM, et al
    Impact of preoperative and intraoperative management on outcomes in osteoradionecrosis requiring free flap reconstruction.
    Head Neck. 2022;44:698-709.
    PubMed     Abstract available


  77. KOHLER HF, Vartanian JG, Pinto CAL, da Silva Rodrigues IFP, et al
    The impact of worst pattern of invasion on the extension of surgical margins in oral squamous cell carcinoma.
    Head Neck. 2022;44:691-697.
    PubMed     Abstract available


    February 2022
  78. MICHMERHUIZEN NL, Ludwig ML, Birkeland AC, Nimmagadda S, et al
    Small molecule profiling to define synergistic EGFR inhibitor combinations in head and neck squamous cell carcinoma.
    Head Neck. 2022 Feb 27. doi: 10.1002/hed.27018.
    PubMed     Abstract available


  79. ALZAHRANI F, Sahovaler A, Mundi N, Rammal A, et al
    Transoral robotic surgery for the identification of unknown primary head and neck squamous cell carcinomas: Its effect on the wait and the weight.
    Head Neck. 2022 Feb 27. doi: 10.1002/hed.27023.
    PubMed     Abstract available


  80. SCHACHTEL MJC, Gandhi M, Bowman JJ, Porceddu SV, et al
    Facial nerve perineural spread from cutaneous squamous cell carcinoma of the head and neck: A single institution analysis of epidemiology, treatment, survival outcomes, and prognostic factors.
    Head Neck. 2022 Feb 27. doi: 10.1002/hed.27017.
    PubMed     Abstract available


  81. JIANG YT, Chen KH, Yang J, Liang ZG, et al
    Prognostic significance of wait time for radical radiotherapy in locoregionally advanced nasopharyngeal carcinoma.
    Head Neck. 2022 Feb 26. doi: 10.1002/hed.27011.
    PubMed     Abstract available


  82. JIANG YT, Chen KH, Liang ZG, Yang J, et al
    A nomogram based on tumor response to induction chemotherapy may predict survival in locoregionally advanced nasopharyngeal carcinoma.
    Head Neck. 2022 Feb 25. doi: 10.1002/hed.27020.
    PubMed     Abstract available


  83. KIM HAJ, Zeng PYF, Sorgini A, Shaikh MH, et al
    Tumor molecular differences associated with outcome disparities of Black patients with head and neck cancer.
    Head Neck. 2022 Feb 21. doi: 10.1002/hed.27007.
    PubMed     Abstract available


  84. WENG JJ, Wei JZ, Li M, Ning LP, et al
    Prognostic value of hypothyroidism in patients undergoing intensity-modulated radiation therapy for nasopharyngeal carcinoma.
    Head Neck. 2022 Feb 16. doi: 10.1002/hed.27006.
    PubMed     Abstract available


  85. LIN W, Cao D, Dong A, Liang S, et al
    Systematic construction and external validation of an immune-related prognostic model for nasopharyngeal carcinoma.
    Head Neck. 2022 Feb 15. doi: 10.1002/hed.26996.
    PubMed     Abstract available


  86. NIGHTINGALE J, Gandhi M, Helena J, Bowman J, et al
    Immunotherapy for the treatment of perineural spread in cutaneous head and neck squamous cell carcinoma: Time to rethink treatment paradigms.
    Head Neck. 2022 Feb 13. doi: 10.1002/hed.27005.
    PubMed     Abstract available


  87. YANG ZC, Luo MJ, Sun XS, Liu LT, et al
    Definitive radiation therapy and liver local therapy in de novo liver metastatic nasopharyngeal carcinoma: Large cohort study.
    Head Neck. 2022 Feb 10. doi: 10.1002/hed.26999.
    PubMed     Abstract available


  88. TAKENAKA Y, Oya R, Takemoto N, Inohara H, et al
    Neutrophil-to-lymphocyte ratio as a prognostic marker for head and neck squamous cell carcinoma treated with immune checkpoint inhibitors: Meta-analysis.
    Head Neck. 2022 Feb 10. doi: 10.1002/hed.26997.
    PubMed     Abstract available


  89. VANGELOV B, Bauer J, Moses D, Smee R, et al
    The effectiveness of skeletal muscle evaluation at the third cervical vertebral level for computed tomography-defined sarcopenia assessment in patients with head and neck cancer.
    Head Neck. 2022 Feb 9. doi: 10.1002/hed.27000.
    PubMed     Abstract available


  90. BARRETTE LX, De Ravin E, Carey RM, Mady LJ, et al
    Reconstruction following transoral robotic surgery for head and neck cancer: Systematic review.
    Head Neck. 2022 Feb 9. doi: 10.1002/hed.26998.
    PubMed     Abstract available


  91. AHSANUDDIN S, Jin R, Sheorey L, Sawhney R, et al
    Understanding basal cell adenocarcinoma of the head and neck: Population-based study.
    Head Neck. 2022;44:483-493.
    PubMed     Abstract available


  92. STEPHEN SE, Murphy JM, Beyer FR, Sellstrom D, et al
    Early postoperative functional outcomes following transoral surgery for oropharyngeal cancer: A systematic review.
    Head Neck. 2022;44:530-547.
    PubMed     Abstract available


  93. DHERE VR, Escott CE, Tian S, Switchenko JM, et al
    The omission of intentional primary site radiation following transoral robotic surgery in 59 patients: No local-regional failures.
    Head Neck. 2022;44:382-390.
    PubMed     Abstract available


  94. HOROWITZ G, De Almeida JR, Berania I, Goldstein DP, et al
    Achieving negative resection margins in oral cavity cancer with masticator space involvement-Is it feasible? International collaborative study.
    Head Neck. 2022;44:453-459.
    PubMed     Abstract available


  95. KAMINAGAKURA E, Tango RN, Cruz-Perez D, Bonan R, et al
    Oral squamous cell carcinoma outcome in adolescent/young adult: Systematic review and meta-analysis.
    Head Neck. 2022;44:548-561.
    PubMed     Abstract available


  96. LAEHN SJ, LoGuidice JA, Hettinger PC, Rein LE, et al
    Postoperative depth of sedation and associated outcomes in free flap transfers to the head and neck.
    Head Neck. 2022;44:391-398.
    PubMed     Abstract available


  97. MERCHANT Y, Rao V, Ramaswamy V
    The stroma in oral potentially malignant disorders: An overlooked denominator?
    Head Neck. 2022;44:572-573.
    PubMed    


  98. WITEK ME, Woody NM, Musunuru HB, Hill PM, et al
    Defining high-risk elective contralateral neck radiation volumes for oropharynx cancer.
    Head Neck. 2022;44:317-324.
    PubMed     Abstract available


  99. BRIL SI, Chargi N, Pezier TF, Tijink BM, et al
    Arterial calcification on preoperative computed tomography imaging as a risk factor for pharyngocutaneous fistula formation after total laryngectomy.
    Head Neck. 2022;44:307-316.
    PubMed     Abstract available


    January 2022
  100. SINGH M, Thankappan K, Balasubramanian D, Pillai V, et al
    Incorporation of adverse features in advanced oral cancer improves precision in staging and patient prognostication.
    Head Neck. 2022 Jan 31. doi: 10.1002/hed.26990.
    PubMed     Abstract available


  101. DEUNING-SMIT E, Custers JAE, Mirosevic S, Takes RP, et al
    Prospective longitudinal study on fear of cancer recurrence in patients newly diagnosed with head and neck cancer: Course, trajectories, and associated factors.
    Head Neck. 2022 Jan 27. doi: 10.1002/hed.26985.
    PubMed     Abstract available


  102. HOYLE JM, Correya TA, Kenzik K, Francisco L, et al
    Factors associated with loss to follow-up after radiation therapy for head and neck cancer.
    Head Neck. 2022 Jan 25. doi: 10.1002/hed.26986.
    PubMed     Abstract available


  103. LIU X, Wu B, Huang J, Qin Y, et al
    Tumor factors associated with in-field failure for nasopharyngeal carcinoma after intensity-modulated radiotherapy.
    Head Neck. 2022 Jan 24. doi: 10.1002/hed.26983.
    PubMed     Abstract available


  104. TUOMI L, Dotevall H, Bergquist H, Petersson K, et al
    The effect of the Shaker head-lift exercise on swallowing function following treatment for head and neck cancer: Results from a randomized, controlled trial with videofluoroscopic evaluation.
    Head Neck. 2022 Jan 23. doi: 10.1002/hed.26982.
    PubMed     Abstract available


  105. GAO P, Peng W, Hu Y
    Prognostic and clinicopathological significance of lymphocyte-to-monocyte ratio in patients with nasopharyngeal carcinoma: A meta-analysis.
    Head Neck. 2022 Jan 20. doi: 10.1002/hed.26952.
    PubMed     Abstract available


  106. EMERSON MA, Farquhar DR, Lenze NR, Sheth S, et al
    Socioeconomic status, access to care, risk factor patterns, and stage at diagnosis for head and neck cancer among black and white patients.
    Head Neck. 2022 Jan 19. doi: 10.1002/hed.26977.
    PubMed     Abstract available


  107. MASCARELLA MA, Patel T, Vendra V, Gardiner L, et al
    Poor treatment tolerance in head and neck cancer patients with low muscle mass.
    Head Neck. 2022 Jan 12. doi: 10.1002/hed.26978.
    PubMed     Abstract available


  108. MEULEMANS J, Vanermen M, Goeleven A, Clement P, et al
    Transoral robotic surgery (TORS) using the da Vinci Xi: prospective analysis of feasibility, safety, and outcomes.
    Head Neck. 2022;44:143-157.
    PubMed     Abstract available


  109. WOISARD V, Balaguer M, Fredouille C, Farinas J, et al
    Construction of an automatic score for the evaluation of speech disorders among patients treated for a cancer of the oral cavity or the oropharynx: The Carcinologic Speech Severity Index.
    Head Neck. 2022;44:71-88.
    PubMed     Abstract available


  110. BIGELOW EO, Harris J, Fakhry C, Gillison ML, et al
    Risk stratification after recurrence of human papillomavirus (HPV)-related and non-HPV-related oropharyngeal cancer: Secondary analysis of NRG Oncology RTOG 0129 and 0522.
    Head Neck. 2022;44:158-167.
    PubMed     Abstract available


  111. YANG ZC, Du CC, Liu T, Liu LT, et al
    Management of first-line palliative chemotherapy for post-treatment metastasis after gemcitabine plus cisplatin induction chemotherapy: Gemcitabine plus cisplatin and non-gemcitabine plus cisplatin chemotherapy.
    Head Neck. 2022;44:113-121.
    PubMed     Abstract available


  112. ZHOU X, Xue D, Qiu J
    Identification of biomarkers related to glycolysis with weighted gene co-expression network analysis in oral squamous cell carcinoma.
    Head Neck. 2022;44:89-103.
    PubMed     Abstract available


  113. BRAUER PR, Byrne PJ, Prendes BL, Ku JA, et al
    Association between hypertension requiring medication and 30-day outcomes in head and neck microvascular surgery.
    Head Neck. 2022;44:168-176.
    PubMed     Abstract available


  114. RE M, Tomasetti M, Monaco F, Amati M, et al
    MiRNome analysis identifying miR-205 and miR-449a as biomarkers of disease progression in intestinal-type sinonasal adenocarcinoma.
    Head Neck. 2022;44:18-33.
    PubMed     Abstract available


    December 2021
  115. YANG L, Xue Y, Wei Z, Ren K, et al
    Local radiotherapy versus nonradiotherapy to distant lesions for metastatic nasopharyngeal carcinoma: A retrospective cohort study.
    Head Neck. 2021 Dec 27. doi: 10.1002/hed.26953.
    PubMed     Abstract available


  116. LANE C, Myers C, Jiang D, Cooke A, et al
    Selected functional outcomes in advanced oral cancer: Comparison of surgery alone versus surgery with postoperative radiotherapy.
    Head Neck. 2021 Dec 23. doi: 10.1002/hed.26968.
    PubMed     Abstract available



  117. Magnetic resonance imaging-based radiogenomics analysis for predicting prognosis and gene expression profile in advanced nasopharyngeal carcinoma.
    Head Neck. 2021 Dec 22. doi: 10.1002/hed.26947.
    PubMed    


  118. MCCUSKER MG, Mehra R, Amr S, Taylor RJ, et al
    Comparison of efficacy and toxicity of chemoradiation regimens for head and neck squamous cell carcinoma primary treatment.
    Head Neck. 2021 Dec 20. doi: 10.1002/hed.26965.
    PubMed     Abstract available


  119. LI W, Xu R, Zhu B, Wang H, et al
    Circular RNAs: Functions and mechanisms in nasopharyngeal carcinoma.
    Head Neck. 2021 Dec 20. doi: 10.1002/hed.26962.
    PubMed     Abstract available


  120. ROSAS RR, Nachbor KM, Handley N, Mathison G, et al
    Preclinical evidence for pioglitazone and bexarotene combination in oral cancer chemoprevention.
    Head Neck. 2021 Dec 20. doi: 10.1002/hed.26959.
    PubMed     Abstract available


  121. KIM MS, Malik NH, Chen H, Poon I, et al
    Stereotactic radiotherapy as planned boost after definitive radiotherapy for head and neck cancers: Systematic review.
    Head Neck. 2021 Dec 19. doi: 10.1002/hed.26948.
    PubMed     Abstract available


  122. SUN Y, Pan H, He Y, Hu C, et al
    Functional roles of the SHCBP1 and KIF23 interaction in modulating the cell-cycle and cisplatin resistance of head and neck squamous cell carcinoma.
    Head Neck. 2021 Dec 17. doi: 10.1002/hed.26961.
    PubMed     Abstract available


  123. HAN SH, Cho D, Mohammad R, Jung YH, et al
    Use of the comprehensive geriatric assessment for the prediction of postoperative complications in elderly patients with head and neck cancer.
    Head Neck. 2021 Dec 17. doi: 10.1002/hed.26958.
    PubMed     Abstract available


  124. LERE-CHEVALEYRE A, Bernadach M, Lambert C, Cassagne L, et al
    Toxicity of induction chemotherapy in head and neck cancer: The central role of skeletal muscle mass.
    Head Neck. 2021 Dec 16. doi: 10.1002/hed.26954.
    PubMed     Abstract available


  125. SHEHAN JN, Alwani T, LeClair J, Mahoney TF, et al
    Social determinants of health and treatment decisions in head and neck cancer.
    Head Neck. 2021 Dec 10. doi: 10.1002/hed.26931.
    PubMed     Abstract available


  126. LIU T, Dai S, Zhang H, Zhong X, et al
    The best choice of induction chemotherapy for patients with locally advanced nasopharyngeal carcinoma: Bayesian network meta-analysis.
    Head Neck. 2021 Dec 4. doi: 10.1002/hed.26932.
    PubMed     Abstract available


  127. YAN F, Lao WP, Nguyen SA, Sharma AK, et al
    Elective neck dissection in salivary gland malignancies: Systematic review and meta-analysis.
    Head Neck. 2021 Dec 4. doi: 10.1002/hed.26923.
    PubMed     Abstract available


  128. JEANS EB, Shiraishi S, Manzar G, Morris LK, et al
    An comparison of acute toxicities and patient-reported outcomes between intensity-modulated proton therapy and volumetric-modulated arc therapy after ipsilateral radiation for head and neck cancers.
    Head Neck. 2021 Dec 3. doi: 10.1002/hed.26937.
    PubMed     Abstract available


  129. ARANTES DAC, da Silva ACG, Freitas NMA, Lima EM, et al
    Safety and efficacy of a mucoadhesive phytomedication containing curcuminoids and Bidens pilosa L. extract in the prevention and treatment of radiochemotherapy-induced oral mucositis: Triple-blind, randomized, placebo-controlled, clinical trial.
    Head Neck. 2021;43:3922-3934.
    PubMed     Abstract available


  130. ROWINSKI E, Magne N, Fayette J, Daguenet E, et al
    Radioresistance and genomic alterations in head and neck squamous cell cancer: Sub-analysis of the ProfiLER protocol.
    Head Neck. 2021;43:3899-3910.
    PubMed     Abstract available


  131. LUO X, Liu S, Chen Y, Qiu X, et al
    Predicting cancer-specific mortality in patients with parotid gland carcinoma by competing risk nomogram.
    Head Neck. 2021;43:3888-3898.
    PubMed     Abstract available


  132. MEHTA MP, Prince R, Butt Z, Maxwell BE, et al
    Evaluating dysphagia and xerostomia outcomes following transoral robotic surgery for patients with oropharyngeal cancer.
    Head Neck. 2021;43:3955-3965.
    PubMed     Abstract available


  133. JAKOB M, Mattes LM, Unger K, Kueffer S, et al
    Human microRNA-182-5p and kinectin 1: Potential biomarkers for prognosis in oral squamous cell carcinoma.
    Head Neck. 2021;43:3707-3719.
    PubMed     Abstract available


  134. RYBKIN A, Kang JJ, Lee A, Kitpanit S, et al
    The effect of short radiation treatment breaks on chemo-radiotherapy for oropharyngeal cancers.
    Head Neck. 2021;43:3796-3809.
    PubMed     Abstract available


  135. BERG M, Adnan A, Hogmo A, Sjodin H, et al
    A national study of health-related quality of life in patients with cancer of the base of the tongue compared to the general population and to patients with tonsillar carcinoma.
    Head Neck. 2021;43:3843-3856.
    PubMed     Abstract available


  136. SOUSA LG, Lazar Neto F, Torman DK, Diaz EM, et al
    Therapeutic approaches and outcomes in patients with larynx or hypopharynx high-grade neuroendocrine carcinoma: A single-center retrospective analysis.
    Head Neck. 2021;43:3788-3795.
    PubMed     Abstract available


  137. CHEN TC, Lo TH, Huang HC, Wang CW, et al
    Outcomes of salvage treatment in patients with recurrent oral squamous cell carcinoma.
    Head Neck. 2021;43:3764-3774.
    PubMed     Abstract available


  138. BOUAOUD J, Schouman T, Bertolus C
    Comment to: "Head and neck osteosarcomas: An analysis of treatment trends and survival outcomes in the United States (2004-2016)".
    Head Neck. 2021;43:4018-4019.
    PubMed    


  139. NEWTON E, Valenzuela D, Foley J, Thamboo A, et al
    Outcomes for the treatment of locoregional recurrent nasopharyngeal cancer: Systematic review and pooled analysis.
    Head Neck. 2021;43:3979-3995.
    PubMed     Abstract available


    November 2021
  140. RAVIKUMAR S, Casellas NJ, Shah S, Rieth K, et al
    Geographic disparities in head and neck cancer survival in Upstate New York 2011-2019.
    Head Neck. 2021 Nov 29. doi: 10.1002/hed.26945.
    PubMed     Abstract available


  141. FENG X, Zhang T, Chou J, Liu L, et al
    Comprehensive gene cluster analysis of head and neck squamous cell carcinoma TCGA RNA-seq data defines B cell immunity-related genes as a robust survival predictor.
    Head Neck. 2021 Nov 29. doi: 10.1002/hed.26944.
    PubMed     Abstract available


  142. AMIN N, Maroun CA, El Asmar M, Alkhatib HH, et al
    Neoadjuvant immunotherapy prior to surgery for mucosal head and neck squamous cell carcinoma: Systematic review.
    Head Neck. 2021 Nov 26. doi: 10.1002/hed.26935.
    PubMed     Abstract available


  143. LI G, Xia YF, Huang YX, Okat D, et al
    Intensity-modulated proton radiation therapy as a radical treatment modality for nasopharyngeal carcinoma in China: A cost-effectiveness analysis.
    Head Neck. 2021 Nov 26. doi: 10.1002/hed.26941.
    PubMed     Abstract available


  144. CHARTERS E, Bogaardt H, Clark J, Milross C, et al
    Functional swallowing outcomes related to radiation exposure to dysphagia and aspiration-related structures in patients with head and neck cancer undergoing definitive and postoperative intensity-modulated radiotherapy.
    Head Neck. 2021 Nov 22. doi: 10.1002/hed.26936.
    PubMed     Abstract available


  145. PIAI V, Jansen F, Dahlslatt K, Verdonck-de Leeuw IM, et al
    Prevalence of neurocognitive and perceived speech deficits in patients with head and neck cancer before treatment: Associations with demographic, behavioral, and disease-related factors.
    Head Neck. 2021 Nov 19. doi: 10.1002/hed.26930.
    PubMed     Abstract available


  146. LENZE NR, Bensen JT, Farnan L, Sheth S, et al
    Association of self-reported financial burden with quality of life and oncologic outcomes in head and neck cancer.
    Head Neck. 2021 Nov 18. doi: 10.1002/hed.26934.
    PubMed     Abstract available


  147. WU EL, Peesay T, Randall JA, Nelson LL, et al
    Increased body mass index predicts prolonged survival in patients with head and neck squamous cell carcinoma.
    Head Neck. 2021 Nov 12. doi: 10.1002/hed.26922.
    PubMed     Abstract available


  148. DIAO K, Wang H, Phan J
    Reply to Letter to the Editor regarding 'Stereotactic radiotherapy for reirradiation of head and neck cancer: Dosimetric details matter'.
    Head Neck. 2021 Nov 12. doi: 10.1002/hed.26920.
    PubMed    


  149. WEST N, Kelly C, Kovarik J, Iqbal MS, et al
    Stereotactic radiotherapy for reirradiation of head and neck cancer: Dosimetric details matter.
    Head Neck. 2021 Nov 12. doi: 10.1002/hed.26925.
    PubMed    


  150. IOCCA O, Copelli C, Ramieri G, Zocchi J, et al
    Antibiotic prophylaxis in head and neck cancer surgery: Systematic review and Bayesian network meta-analysis.
    Head Neck. 2021 Nov 6. doi: 10.1002/hed.26908.
    PubMed     Abstract available


  151. JING Z, Guo S, Li Y, Liang Z, et al
    FOXC2/ADAM12-dependent radiosensitivity of head and neck squamous cell carcinoma cells.
    Head Neck. 2021 Nov 3. doi: 10.1002/hed.26918.
    PubMed     Abstract available


  152. BULBUL MG, Genovese TJ, Hagan K, Rege S, et al
    Salvage surgery for recurrent squamous cell carcinoma of the head and neck: Systematic review and meta-analysis.
    Head Neck. 2021 Nov 3. doi: 10.1002/hed.26898.
    PubMed     Abstract available


  153. SICHERO L, Tagliabue M, Mota G, Ferreira S, et al
    Biomarkers of human papillomavirus (HPV)-driven head and neck cancer in Latin America and Europe study: Study design and HPV DNA/p16(INK4a) status.
    Head Neck. 2021 Nov 2. doi: 10.1002/hed.26912.
    PubMed     Abstract available


  154. MANI S, Anbarasan S, Singh CA, Kumar R, et al
    In reference to "Surgical treatment of the neck in patients with salivary gland carcinoma".
    Head Neck. 2021;43:3697-3698.
    PubMed    


  155. WESTERGAARD-NIELSEN M, Godballe C, Grau Eriksen J, Rosenkilde Larsen S, et al
    Reply to Letter to the Editor regarding "In reference to Surgical treatment of the neck in patients with salivary gland carcinoma".
    Head Neck. 2021;43:3699-3700.
    PubMed    


  156. MIRZA FA, Johnson CZ, Byrd JK, Albergotti WG 3rd, et al
    Treatment trends for advanced oropharyngeal squamous cell carcinoma in the era of human papillomavirus.
    Head Neck. 2021;43:3476-3492.
    PubMed     Abstract available


  157. VOORA RS, Stramiello JA, Sumner WA, Finegersh A, et al
    Quality improvement intervention to reduce time to postoperative radiation in head and neck free flap patients.
    Head Neck. 2021;43:3530-3539.
    PubMed     Abstract available


  158. KIERCE J, Shi Y, Klieb H, Blanas N, et al
    Identification of specific clinical risk factors associated with the malignant transformation of oral epithelial dysplasia.
    Head Neck. 2021;43:3552-3561.
    PubMed     Abstract available


  159. LUO F, Huang L, Gong X, Han Z, et al
    Microwave ablation of benign thyroid nodules: 3-year follow-up outcomes.
    Head Neck. 2021;43:3437-3447.
    PubMed     Abstract available


  160. EDMOND M, Nenclares P, Harrington K, Ap Dafydd D, et al
    What is the role of the surgeon in the management of head and neck mucosal melanoma in the immunotherapy era?
    Head Neck. 2021;43:3498-3503.
    PubMed     Abstract available


  161. ZHUANG SM, Xie LE, Pang F, Zhong QY, et al
    Role of primary tumor resection in patients with metastatic medullary thyroid cancer who have unresectable distant metastases.
    Head Neck. 2021;43:3386-3392.
    PubMed     Abstract available


  162. FANTINI M, Crosetti E, Affaniti R, Sprio AE, et al
    Preoperative prognostic factors for functional and clinical outcomes after open partial horizontal laryngectomies.
    Head Neck. 2021;43:3459-3467.
    PubMed     Abstract available


  163. AMINI A, Morgan R, Meyer E, Fakhoury K, et al
    Outcomes between intensity-modulated radiation therapy versus 3D-conformal in early stage glottic cancer.
    Head Neck. 2021;43:3393-3403.
    PubMed     Abstract available


  164. KIMURA B, Nagelberg J, Koo SJ, Bykowski J, et al
    Inappropriate requesting of parathyroid scintigraphy at an academic medical center.
    Head Neck. 2021;43:3404-3407.
    PubMed     Abstract available


  165. KREINBRINK PJ, Mierzwa ML, Huth B, Redmond KP, et al
    Adjuvant radiation and cetuximab improves local control in head and neck cutaneous squamous cell carcinoma: Phase II study.
    Head Neck. 2021;43:3408-3416.
    PubMed     Abstract available


  166. SOLIMENO LS, Park YM, Lim JY, Koh YW, et al
    Treatment outcomes of neoadjuvant chemotherapy and transoral robotic surgery in locoregionally advanced laryngopharyngeal carcinoma.
    Head Neck. 2021;43:3429-3436.
    PubMed     Abstract available


  167. PANDEY S, Soland TM, Bjerkli IH, Sand LP, et al
    Combined loss of expression of involucrin and cytokeratin 13 is associated with poor prognosis in squamous cell carcinoma of mobile tongue.
    Head Neck. 2021;43:3374-3385.
    PubMed     Abstract available


  168. OBERSTE M, Riders A, Abbaspour B, Kerschke L, et al
    Improvement of patient stratification in human papilloma virus-associated oropharyngeal squamous cell carcinoma by defining a multivariable risk score.
    Head Neck. 2021;43:3314-3323.
    PubMed     Abstract available


  169. SMITH DH, Raslan S, Samuels MA, Iglesias T, et al
    Current salivary biomarkers for detection of human papilloma virus-induced oropharyngeal squamous cell carcinoma.
    Head Neck. 2021;43:3618-3630.
    PubMed     Abstract available


  170. DAY AT, Yang AM, Tanamal P, Blackwell JM, et al
    Extracapsular extension, pathologic node status, and adjuvant treatment in primary surgery patients with human papillomavirus-mediated oropharyngeal cancer: National hospital-based retrospective cohort analysis.
    Head Neck. 2021;43:3345-3363.
    PubMed     Abstract available


  171. QUAN DL, Sukari A, Nagasaka M, Kim H, et al
    Gastrostomy tube dependence and patient-reported quality of life outcomes based on type of treatment for human papillomavirus-associated oropharyngeal cancer: Systematic review and meta-analysis.
    Head Neck. 2021;43:3681-3696.
    PubMed     Abstract available


  172. ADEOYE J, Tan JY, Ip CM, Choi SW, et al
    "Fact or fiction?": Oral cavity cancer in nonsmoking, nonalcohol drinking patients as a distinct entity-Scoping review.
    Head Neck. 2021;43:3662-3680.
    PubMed     Abstract available


  173. MASHRAH MA, Al-Sharani HM, Al-Aroomi MA, Abdelrehem A, et al
    Surgical interventions for management of benign parotid tumors: Systematic review and network meta-analysis.
    Head Neck. 2021;43:3631-3645.
    PubMed     Abstract available


  174. ZAKRZEWSKI M, Gannon OM, Panizza BJ, Saunders NA, et al
    Human papillomavirus infection and tumor microenvironment are associated with the microbiota in patients with oropharyngeal cancers-pilot study.
    Head Neck. 2021;43:3324-3330.
    PubMed     Abstract available


  175. ANAKAPU K, Wilson M, Findlay M, Brown T, et al
    Nutritional outcomes in patients undergoing transoral robotic surgery for head and neck cancers compared to conventional open surgery. A systematic review.
    Head Neck. 2021 Nov 1. doi: 10.1002/hed.26913.
    PubMed     Abstract available


    October 2021
  176. BRIL SI, Al-Mamgani A, Chargi N, Remeijer P, et al
    The association of pretreatment low skeletal muscle mass with chemotherapy dose-limiting toxicity in patients with head and neck cancer undergoing primary chemoradiotherapy with high-dose cisplatin.
    Head Neck. 2021 Oct 29. doi: 10.1002/hed.26919.
    PubMed     Abstract available


  177. SULTANIA M, Imaduddin M, S V Deo S, Kar M, et al
    Role of metronomic therapy for advanced oral cancers and predictors of response: A multi-institutional feasibility study.
    Head Neck. 2021 Oct 28. doi: 10.1002/hed.26904.
    PubMed     Abstract available


  178. ZHOU C, Cao H, Meng X, Zhang Q, et al
    Lnc-MEG3 inhibits invasion, migration, and epithelial- mesenchymal transition of nasopharyngeal carcinoma cells by regulating sequestosome 1.
    Head Neck. 2021 Oct 27. doi: 10.1002/hed.26917.
    PubMed     Abstract available


  179. NALLANI R, Smith JB, Penn JP, Bur AM, et al
    Decision regret 3 and 6 months after treatment for head and neck cancer: An observational study of associations with clinicodemographics, anxiety, and quality of life.
    Head Neck. 2021 Oct 27. doi: 10.1002/hed.26911.
    PubMed     Abstract available


  180. CHINTALA S, Quist KM, Gonzalez-DeWhitt PA, Katzenellenbogen RA, et al
    High expression of NFX1-123 in HPV positive head and neck squamous cell carcinomas.
    Head Neck. 2021 Oct 25. doi: 10.1002/hed.26906.
    PubMed     Abstract available


  181. LIU LT, Liang YJ, Guo SS, Xie Y, et al
    Identifying distinct risks of treatment failure in nasopharyngeal carcinoma: A study based on the dynamic changes in peripheral blood lymphocytes, monocytes, N classification, and plasma Epstein-Barr virus DNA.
    Head Neck. 2021 Oct 12. doi: 10.1002/hed.26897.
    PubMed     Abstract available


  182. AMR S, Ioffe D, Suzuki I, Mehra R, et al
    Treatment modalities, adverse events, and survival outcomes in older patients with head and neck squamous cell carcinoma.
    Head Neck. 2021 Oct 10. doi: 10.1002/hed.26893.
    PubMed     Abstract available


  183. COGNETTI DM, Johnson JM, Curry JM, Kochuparambil ST, et al
    Phase 1/2a, open-label, multicenter study of RM-1929 photoimmunotherapy in patients with locoregional, recurrent head and neck squamous cell carcinoma.
    Head Neck. 2021 Oct 9. doi: 10.1002/hed.26885.
    PubMed     Abstract available


  184. LOU DI, Dietrich MS, Deng J, Murphy BA, et al
    Mechanisms of pain and their manifestations in head and neck cancer: Importance of classifying pain subtypes.
    Head Neck. 2021 Oct 7. doi: 10.1002/hed.26859.
    PubMed     Abstract available


  185. LARSEN MHH, Scott SI, Channir HI, Madsen AKO, et al
    Days alive and out of hospital following transoral robotic surgery: Cohort study of 262 patients with head and neck cancer.
    Head Neck. 2021 Oct 3. doi: 10.1002/hed.26880.
    PubMed     Abstract available


  186. HOLCOMB AJ, Richmon JD
    Surgical margins in a single-modality transoral robotic surgery: A conundrum-Reply.
    Head Neck. 2021;43:3219-3221.
    PubMed    


  187. SHAH SB, Malik A
    Surgical margins in a single modality transoral robotic surgery-A conundrum.
    Head Neck. 2021;43:3217-3218.
    PubMed    


  188. BASTERRA J, Oishi N, Lopez I, Otero M, et al
    Use of monopolar microelectrodes and radiofrequency in the treatment of arytenoid edema after partial horizontal laryngectomy and radiotherapy.
    Head Neck. 2021;43:3245-3248.
    PubMed     Abstract available


  189. PAI P, Tuljapurkar V, Balaji A, Mishra A, et al
    Comparative study of functional outcomes following surgical treatment of early tongue cancer.
    Head Neck. 2021;43:3142-3152.
    PubMed     Abstract available


  190. WINDON MJ, Fakhry C, Margalit DN, Dey T, et al
    Epidemiologic distinctions between base of tongue and tonsil oropharyngeal carcinomas.
    Head Neck. 2021;43:3076-3085.
    PubMed     Abstract available


  191. HE C, Liu J, Hu S, Qing H, et al
    Improvement of image quality of laryngeal squamous cell carcinoma using noise-optimized virtual monoenergetic image and nonlinear blending image algorithms in dual-energy computed tomography.
    Head Neck. 2021;43:3125-3131.
    PubMed     Abstract available


  192. UEHARA T, Doi H, Ishikawa K, Inada M, et al
    Serum lactate dehydrogenase is a predictive biomarker in patients with oropharyngeal cancer undergoing radiotherapy: Retrospective study on predictive factors.
    Head Neck. 2021;43:3132-3141.
    PubMed     Abstract available


  193. SHUKLA N, Ma Y, Megwalu UC
    The role of insurance status as a mediator of racial disparities in oropharyngeal cancer outcomes.
    Head Neck. 2021;43:3116-3124.
    PubMed     Abstract available


  194. ALSUBAIE HM, Alsini AY, Alsubaie KM, Abu-Zaid A, et al
    Glutamine for prevention and alleviation of radiation-induced oral mucositis in patients with head and neck squamous cell cancer: Systematic review and meta-analysis of controlled trials.
    Head Neck. 2021;43:3199-3213.
    PubMed     Abstract available


  195. KARTHIK K, Dhiwakar M
    Predictors of surgical site infection and pneumonia following oral cavity tumor surgery.
    Head Neck. 2021;43:3106-3115.
    PubMed     Abstract available


  196. SUN L, Shimunov D, Tan EX, Swisher-Mcclure S, et al
    Survival and toxicity in patients with human papilloma virus-associated oropharyngeal squamous cell cancer receiving trimodality therapy including transoral robotic surgery.
    Head Neck. 2021;43:3053-3061.
    PubMed     Abstract available


  197. MEMBRENO PV, Luttrell JB, Mamidala MP, Schwartz DL, et al
    Outcomes of primary radiotherapy with or without chemotherapy for advanced oral cavity squamous cell carcinoma: Systematic review.
    Head Neck. 2021;43:3165-3176.
    PubMed     Abstract available


  198. ROWE LM, Connor NP, Russell JA
    Respiratory-swallow coordination in a rat model of chemoradiation.
    Head Neck. 2021;43:2954-2966.
    PubMed     Abstract available


  199. MENDELSOHN AH, Lawson G
    Single-port transoral robotic surgery hypopharyngectomy.
    Head Neck. 2021;43:3234-3237.
    PubMed     Abstract available


  200. MADY LJ, Poonia SK, Baddour K, Snyder V, et al
    Consensus of free flap complications: Using a nomenclature paradigm in microvascular head and neck reconstruction.
    Head Neck. 2021;43:3032-3041.
    PubMed     Abstract available


  201. GAINO F, Gorphe P, Vander Poorten V, Holsinger FC, et al
    Preoperative predictors of difficult oropharyngeal exposure for transoral robotic surgery: The Pharyngoscore.
    Head Neck. 2021;43:3010-3021.
    PubMed     Abstract available


  202. KING C, Elsherif N, Kirwan R, Schilling C, et al
    Serial step sections at narrow intervals with immunohistochemistry are required for accurate histological assessment of sentinel lymph node biopsy in oral squamous cell carcinoma.
    Head Neck. 2021;43:2985-2993.
    PubMed     Abstract available


  203. LAW RH, Quan DL, Stefan AJ, Peterson EL, et al
    Hyperparathyroidism subsequent to radioactive iodine therapy for Graves' disease.
    Head Neck. 2021;43:2994-3000.
    PubMed     Abstract available


  204. KIM DH, Kim GJ, Kim SW, Hwang SH, et al
    Predictive value of ipsilateral central lymph node metastasis for contralateral central lymph node metastasis in patients with thyroid cancer: Systematic review and meta-analysis.
    Head Neck. 2021;43:3177-3184.
    PubMed     Abstract available


  205. LOW CM, Balakrishnan K, Smith BM, Stokken JK, et al
    Sinonasal adenocarcinoma: Population-based analysis of demographic and socioeconomic disparities.
    Head Neck. 2021;43:2946-2953.
    PubMed     Abstract available


  206. BELTRAMINI GA, Belloni LM, Fusco N, Sacconi A, et al
    Comparing prognostic utility between the 8th edition of TNM staging system and the lymph node ratio for oral squamous cell carcinoma.
    Head Neck. 2021;43:2876-2882.
    PubMed     Abstract available


  207. PARHAR HS, Weinstein GS, O'Malley BW Jr, Shimunov D, et al
    Oncologic outcomes of transoral robotic surgery for HPV-negative oropharyngeal carcinomas.
    Head Neck. 2021;43:2923-2934.
    PubMed     Abstract available


  208. BARBON CEA, Yao CMKL, Alvarez CP, Goepfert RP, et al
    Dysphagia profiles after primary transoral robotic surgery or radiation for oropharyngeal cancer: A registry analysis.
    Head Neck. 2021;43:2883-2895.
    PubMed     Abstract available


  209. WONG A, Zhu D, Tong JY, Ko A, et al
    The jaw-dropping costs of oral cavity cancer malpractice.
    Head Neck. 2021;43:2869-2875.
    PubMed     Abstract available


  210. THAKAR A, Panda S, Kakkar A, Singh V, et al
    A matched pair analysis of oncological outcomes in human papillomavirus-negative oropharyngeal squamous cell carcinoma: Transoral surgery versus radiotherapy or concurrent chemoradiation.
    Head Neck. 2021;43:2896-2906.
    PubMed     Abstract available


    September 2021
  211. SANABRIA A, Pinillos P, Lira RB, Shah JP, et al
    Current therapeutic options for low-risk papillary thyroid carcinoma: A scoping evidence review.
    Head Neck. 2021 Sep 30. doi: 10.1002/hed.26883.
    PubMed     Abstract available


  212. VILASECA I, Aviles-Jurado FX, Valduvieco I, Berenguer J, et al
    Transoral laser microsurgery in locally advanced laryngeal cancer: Prognostic impact of anterior versus posterior compartments.
    Head Neck. 2021 Sep 27. doi: 10.1002/hed.26878.
    PubMed     Abstract available


  213. FENG G, Wang T, Xue F, Qi Y, et al
    Identification of enhancer RNAs for the prognosis of head and neck squamous cell carcinoma.
    Head Neck. 2021 Sep 27. doi: 10.1002/hed.26877.
    PubMed     Abstract available


  214. XU X, Ong YK, Loh WS, Anil G, et al
    Clinical predictors of internal carotid artery blowout in patients with radiated nasopharyngeal carcinoma.
    Head Neck. 2021 Sep 24. doi: 10.1002/hed.26869.
    PubMed     Abstract available


  215. SATO MP, Otsuki N, Kitano M, Ishikawa K, et al
    Up-front neck dissection followed by chemoradiotherapy for T1-T3 hypopharyngeal cancer with advanced nodal involvement.
    Head Neck. 2021 Sep 22. doi: 10.1002/hed.26881.
    PubMed     Abstract available


  216. VAN DER ELST S, Bardash Y, Wotman M, Kraus D, et al
    The prognostic impact of depression or depressive symptoms on patients with head and neck cancer: A systematic review and meta-analysis.
    Head Neck. 2021 Sep 15. doi: 10.1002/hed.26868.
    PubMed     Abstract available


  217. KU PKM, Vlantis AC, Hui TSC, Yeung DCM, et al
    Assessment of pharyngeal motor function using a novel velopharyngeal squeeze maneuver and a novel endoscopic pharyngeal contraction grade scale in patients with dysphagia after radiotherapy for nasopharyngeal carcinoma.
    Head Neck. 2021 Sep 15. doi: 10.1002/hed.26871.
    PubMed     Abstract available


  218. GAO Y, Mao Y, Lu S, Tan L, et al
    Magnetic resonance imaging-based radiogenomics analysis for predicting prognosis and gene expression profile in advanced nasopharyngeal carcinoma.
    Head Neck. 2021 Sep 13. doi: 10.1002/hed.26867.
    PubMed     Abstract available


  219. METZGER K, Mrosek J, Zittel S, Pilz M, et al
    Treatment delay and tumor size in patients with oral cancer during the first year of the COVID-19 pandemic.
    Head Neck. 2021 Sep 8. doi: 10.1002/hed.26858.
    PubMed     Abstract available


  220. SINGH P, McDonald L, Waldenberger D, Welslau M, et al
    Pooled analysis of nivolumab treatment in patients with recurrent/metastatic squamous cell carcinoma of the head and neck in the United States and Germany.
    Head Neck. 2021 Sep 6. doi: 10.1002/hed.26853.
    PubMed     Abstract available


  221. SINGH A, Rosen EB, Randazzo JD, Estilo CL, et al
    Intraoral radiation stents-Primer for clinical use in head and neck cancer therapy.
    Head Neck. 2021 Sep 4. doi: 10.1002/hed.26848.
    PubMed     Abstract available


  222. FOLEY J, Ward EC, Burns CL, Nund RL, et al
    Speech pathology service enhancement for people with head and neck cancer living in rural areas: Using a concept mapping approach to inform service change.
    Head Neck. 2021 Sep 3. doi: 10.1002/hed.26850.
    PubMed     Abstract available


  223. WANG S, Stanisce L, Begun Z, Wilson T, et al
    Osteoradionecrosis of the hyoid presenting as acute airway compromise.
    Head Neck. 2021;43:E41-E44.
    PubMed     Abstract available


  224. SAWHNEY R, Ahsanuddin S, Sheorey L, Wassef DW, et al
    Understanding giant cell sarcoma of the head and neck: A population-based study.
    Head Neck. 2021;43:2786-2794.
    PubMed     Abstract available


  225. KONISHI M, Sakamoto S, Ogawa I, Yoshioka Y, et al
    Relationships between intraoral ultrasonographic and histopathological findings in patients with tongue cancer.
    Head Neck. 2021;43:2778-2785.
    PubMed     Abstract available


  226. GILAT H, Vainer I, Avishai G, Maymon SL, et al
    Radioiodine therapy induced sialadenitis versus chronic idiopathic sialadenitis-Presentation and outcomes.
    Head Neck. 2021;43:2724-2730.
    PubMed     Abstract available


  227. MOONEY CP, Clark JR, Shannon K, Palme CE, et al
    The significance of regional metastasis location in head and neck cutaneous squamous cell carcinoma.
    Head Neck. 2021;43:2705-2711.
    PubMed     Abstract available


  228. SHINDE A, Jones B, Luu M, Li R, et al
    Factors predictive of 90-day mortality after surgical resection for oral cavity cancer: Development of a recursive partitioning analysis for risk stratification.
    Head Neck. 2021;43:2731-2739.
    PubMed     Abstract available


  229. BOEVE K, Mastik MF, Slagter-Menkema L, van Dijk BAC, et al
    Cortactin expression assessment improves patient selection for a watchful waiting strategy in pT1cN0-staged oral squamous cell carcinomas with a tumor infiltration depth below 4 mm.
    Head Neck. 2021;43:2688-2697.
    PubMed     Abstract available


  230. HORWICH P, Gundale A, Patin S, Flores J, et al
    Impact of smoking on stage-specific survival in human papilloma virus-associated oropharyngeal squamous cell carcinoma.
    Head Neck. 2021;43:2698-2704.
    PubMed     Abstract available


  231. KO CA, Fang KH, Hsu CM, Lee YC, et al
    The preoperative C-reactive protein-lymphocyte ratio and the prognosis of oral cavity squamous cell carcinoma.
    Head Neck. 2021;43:2740-2754.
    PubMed     Abstract available


  232. TURCHAN WT, Korpics MC, Rooney M, Koshy M, et al
    Impact of anatomic site of distant metastasis on survival in salivary gland cancers.
    Head Neck. 2021;43:2589-2601.
    PubMed     Abstract available


  233. YU L, Zheng M, Ren J, Hu J, et al
    Supracricoid partial laryngectomy with cricohyoidoepiglottopexy for patients with laryngeal cicatricial stenosis: Safety and efficacy.
    Head Neck. 2021;43:2634-2643.
    PubMed     Abstract available


  234. CHAN SA, Van Abel KM, Lewis JE, Routman DM, et al
    Mucoepidermoid carcinoma of the parotid gland: Twenty-year experience in treatment and outcomes.
    Head Neck. 2021;43:2663-2671.
    PubMed     Abstract available


  235. LI H, McGill M, Putri N, Yuan A, et al
    Margin status, local control, and disease-specific survival in surgically resected parotid carcinomas with parapharyngeal extension.
    Head Neck. 2021;43:2644-2654.
    PubMed     Abstract available


    August 2021
  236. GEARING PF, Daly JF, Tang NSJ, Singh K, et al
    Risk factors for surgical site infection in free-flap reconstructive surgery for head and neck cancer: A retrospective Australian cohort study.
    Head Neck. 2021 Aug 18. doi: 10.1002/hed.26837.
    PubMed     Abstract available


  237. BHOLA NE, Njatcha C, Hu L, Lee ED, et al
    PD-L1 is upregulated via BRD2 in head and neck squamous cell carcinoma models of acquired cetuximab resistance.
    Head Neck. 2021 Aug 3. doi: 10.1002/hed.26827.
    PubMed     Abstract available


  238. HAYDEN RE, Chang BA, Mullin DP, Patel AK, et al
    Reply to Letter to the Editor regarding "Surgical armamentarium for salvage laryngectomy closure reinforcements".
    Head Neck. 2021;43:2559.
    PubMed    


  239. ARUN I, Maity N, Hameed S, Jain PV, et al
    Reply to Letter to the Editor regarding "Lymph node characteristics and their prognostic significance in oral squamous cell carcinoma".
    Head Neck. 2021;43:2556.
    PubMed    


  240. MAMIC M, Luksic I
    Lymph node characteristics and their prognostic significance in oral squamous cell carcinoma.
    Head Neck. 2021;43:2554-2555.
    PubMed    


  241. GALLI A, Bondi S, Canevari C, Tulli M, et al
    High-risk early-stage oral tongue squamous cell carcinoma, when free margins are not enough: Critical review.
    Head Neck. 2021;43:2510-2522.
    PubMed     Abstract available


  242. XU B, Ghossein R, Ho A, Viswanathan K, et al
    Diagnostic discrepancy in second opinion reviews of primary epithelial neoplasms involving salivary gland: An 11-year experience from a tertiary referral center focusing on useful pathologic approaches and potential clinical impacts.
    Head Neck. 2021;43:2497-2509.
    PubMed     Abstract available


  243. HOLCOMB AJ, Herberg M, Strohl M, Ochoa E, et al
    Impact of surgical margins on local control in patients undergoing single-modality transoral robotic surgery for HPV-related oropharyngeal squamous cell carcinoma.
    Head Neck. 2021;43:2434-2444.
    PubMed     Abstract available


  244. MENDERICO JUNIOR GM, Theodoro TR, Pasini FS, de Menezes Ishikawa M, et al
    MicroRNA-mediated extracellular matrix remodeling in squamous cell carcinoma of the oral cavity.
    Head Neck. 2021;43:2364-2376.
    PubMed     Abstract available


  245. KWAK MS, Eun YG, Lee JW, Lee YC, et al
    Development of a machine learning model for the prediction of nodal metastasis in early T classification oral squamous cell carcinoma: SEER-based population study.
    Head Neck. 2021;43:2316-2324.
    PubMed     Abstract available


  246. MA CY, Guo B, Shen Y, Zheng ZW, et al
    A novel application of superior thyroid artery perforator flaps for medium-sized intraoral reconstructions: Retrospective analysis of 12 cases.
    Head Neck. 2021;43:2297-2306.
    PubMed     Abstract available


  247. MOYA-PLANA A, Mangin D, Blanchard P, Obongo R, et al
    Prognostic value and therapeutic implications of nodal involvement in head and neck mucosal melanoma.
    Head Neck. 2021;43:2325-2331.
    PubMed     Abstract available


    July 2021
  248. STOKES WA, Molina E, McDermott JD, Morgan RL, et al
    Survival impact of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in head and neck cancer.
    Head Neck. 2021 Jul 21. doi: 10.1002/hed.26809.
    PubMed     Abstract available


  249. SCHLIJPER R, Bos S, Hamilton SN, Tran E, et al
    Ninety-day mortality after radiotherapy for head and neck cancer: A population-based comparison between rural and urban patients.
    Head Neck. 2021 Jul 21. doi: 10.1002/hed.26819.
    PubMed     Abstract available


  250. KIM MJ, Back K, Choe JH, Kim JH, et al
    Feasibility of lateral sentinel lymph node biopsy in medullary thyroid cancer: A surrogate tool for determining prophylactic lateral neck dissection-A pilot study.
    Head Neck. 2021 Jul 20. doi: 10.1002/hed.26808.
    PubMed     Abstract available


  251. DIAO K, Nguyen TP, Moreno AC, Reddy JP, et al
    Stereotactic body ablative radiotherapy for reirradiation of small volume head and neck cancers is associated with prolonged survival: A large, single-institution, modern cohort study.
    Head Neck. 2021 Jul 16. doi: 10.1002/hed.26820.
    PubMed     Abstract available


  252. THANKAPPAN K, Subramanian S, Balasubramanian D, Kuriakose MA, et al
    Cost-effectiveness of oral cancer screening approaches by visual examination: A systematic review.
    Head Neck. 2021 Jul 14. doi: 10.1002/hed.26816.
    PubMed     Abstract available


  253. DING Z, Li Y, Pan X, Xuan M, et al
    Sentinel lymph node biopsy versus elective neck dissection in squamous cell carcinoma of the oral cavity with a clinically N0 neck: A systematic review and meta-analysis of prospective studies.
    Head Neck. 2021 Jul 10. doi: 10.1002/hed.26803.
    PubMed     Abstract available


  254. SHIGA K, Nibu KI, Fujimoto Y, Asakage T, et al
    Sites of invasion of cancer of the external auditory canal predicting oncologic outcomes.
    Head Neck. 2021 Jul 9. doi: 10.1002/hed.26800.
    PubMed     Abstract available


  255. REID P, Staudacher AH, Marcu LG, Olver I, et al
    Characteristic differences in radiation-induced DNA damage response in human papillomavirus-negative and human papillomavirus-positive head and neck cancers with accumulation of fractional radiation dose.
    Head Neck. 2021 Jul 8. doi: 10.1002/hed.26802.
    PubMed     Abstract available


  256. BADDOUR K, Fadel M, Zhao M, Corcoran M, et al
    The cost of cure: Examining objective and subjective financial toxicity in head and neck cancer survivors.
    Head Neck. 2021 Jul 8. doi: 10.1002/hed.26801.
    PubMed     Abstract available


  257. CHILLAKURU Y, Benito DA, Strum D, Mehta V, et al
    Transoral robotic surgery versus nonrobotic resection of oropharyngeal squamous cell carcinoma.
    Head Neck. 2021;43:2259-2273.
    PubMed     Abstract available


  258. PFISTER NT, Beitler JJ, Stokes WA
    Contralateral nodal spread in human papillomavirus-associated oropharyngeal cancer: Can more details help guide contralateral neck coverage?
    Head Neck. 2021;43:2253.
    PubMed    


  259. HUSAIN S, Lohia S, Petkov V, Blackwell T, et al
    Disparities and guideline adherence for HPV testing among patients with oropharyngeal squamous cell carcinoma, NCDB, and SEER.
    Head Neck. 2021;43:2110-2123.
    PubMed     Abstract available


  260. HENN TE, Anderson AN, Hollett YR, Sutton TL, et al
    Circulating hybrid cells predict presence of occult nodal metastases in oral cavity carcinoma.
    Head Neck. 2021;43:2193-2201.
    PubMed     Abstract available


  261. CHEN L, Lin G, Qian J, Chen Z, et al
    A dynamic prognostic nomogram to predict the benefit from surgical treatment modality for patients with laryngeal squamous cell carcinoma.
    Head Neck. 2021;43:2148-2158.
    PubMed     Abstract available


  262. SMITH DK, Freundlich RE, Shinn JR, Wood CB, et al
    An improved predictive model for postoperative pulmonary complications after free flap reconstructions in the head and neck.
    Head Neck. 2021;43:2178-2184.
    PubMed     Abstract available


  263. TOMBLINSON CM, Fletcher GP, Hu LS, Mi L, et al
    Determination of posterolateral oropharyngeal wall thickness and the potential implications for transoral surgical margins in tonsil cancer.
    Head Neck. 2021;43:2185-2192.
    PubMed     Abstract available


  264. PANNU JS, Simpson MC, Adjei Boakye E, Massa ST, et al
    Survival outcomes for head and neck patients with Medicaid: A health insurance paradox.
    Head Neck. 2021;43:2136-2147.
    PubMed     Abstract available


  265. SAIYED FK, Guo T, Johnson F, Myers JN, et al
    Characterizing distant metastases and survival in oropharyngeal squamous cell carcinoma.
    Head Neck. 2021;43:2101-2109.
    PubMed     Abstract available


  266. WESTERGAARD-NIELSEN M, Moller S, Godballe C, Grau Eriksen J, et al
    Prognostic scoring models in parotid gland carcinoma.
    Head Neck. 2021;43:2081-2090.
    PubMed     Abstract available


  267. UDOVICICH C, Daniell J, Wiesenfeld D, Bressel M, et al
    Contralateral neck failure in oral tongue cancer: Outcomes from two centers using predefined treatment criteria.
    Head Neck. 2021;43:2024-2031.
    PubMed     Abstract available


  268. CHARTERS E, Wu R, Milross C, Bogaardt H, et al
    Swallowing and communication outcomes following primary transoral robotic surgery.
    Head Neck. 2021;43:2013-2023.
    PubMed     Abstract available


  269. LASKAR SG, Pai P, Sinha S, Budrukkar A, et al
    Intensity-modulated radiation therapy for nasal cavity and paranasal sinus tumors: Experience from a single institute.
    Head Neck. 2021;43:2045-2057.
    PubMed     Abstract available


  270. HAZIM AZ, Reed CT, Price KA, Foote RL, et al
    Survival outcomes in locally advanced cutaneous squamous cell carcinoma presenting with clinical perineural invasion alone.
    Head Neck. 2021;43:1995-2001.
    PubMed     Abstract available


    June 2021
  271. GAO J, Tseng CC, Barinsky GL, Povolotskiy R, et al
    Exploratory analysis on the association of mental health disorders with in-hospital postoperative complications and mortality in head and neck cancer surgery.
    Head Neck. 2021 Jun 28. doi: 10.1002/hed.26791.
    PubMed     Abstract available


  272. BURBURE N, Handorf E, Ridge JA, Bauman J, et al
    Prognostic significance of human papillomavirus status and treatment modality in hypopharyngeal cancer.
    Head Neck. 2021 Jun 24. doi: 10.1002/hed.26793.
    PubMed     Abstract available


  273. FATEHI KS, Malik A
    Elective neck dissection and its extent in salivary gland cancers: A dilemma.
    Head Neck. 2021 Jun 18. doi: 10.1002/hed.26777.
    PubMed    


  274. WESTERGAARD-NIELSEN M, Godballe C, Eriksen JG, Larsen SR, et al
    Reply to Letter to the Editor regarding "Elective neck dissection and its extent in Salivary gland cancers: A Dilemma".
    Head Neck. 2021 Jun 18. doi: 10.1002/hed.26778.
    PubMed    


  275. RICH BJ, Schumacher LD, Sargi ZB, Masforroll M, et al
    Opioid use patterns in patients with head and neck cancer receiving radiation therapy: A single-institution retrospective analysis characterizing patients who did not require opioid therapy.
    Head Neck. 2021 Jun 18. doi: 10.1002/hed.26785.
    PubMed     Abstract available


  276. WEIZMAN B, Golan N, Ronen O
    Effect of socioeconomic status on survival in patients with head and neck cancer.
    Head Neck. 2021 Jun 16. doi: 10.1002/hed.26788.
    PubMed     Abstract available


  277. BERGAMINI C, Ferris RL, Xie J, Mariani G, et al
    Bleeding complications in patients with squamous cell carcinoma of the head and neck.
    Head Neck. 2021 Jun 12. doi: 10.1002/hed.26772.
    PubMed     Abstract available


  278. CAVALHEIRO BG, de Matos LL, Leite AKN, Kulcsar MAV, et al
    Survival in differentiated thyroid carcinoma: A comparison between the 7th and 8th editions of the AJCC/UICC TNM staging system and the ATA initial risk stratification system.
    Head Neck. 2021 Jun 1. doi: 10.1002/hed.26773.
    PubMed     Abstract available


  279. WESTERGAARD-NIELSEN M, Godballe C, Grau Eriksen J, Larsen SR, et al
    Surgical treatment of the neck in patients with salivary gland carcinoma.
    Head Neck. 2021;43:1898-1911.
    PubMed     Abstract available


  280. SHEPPARD SC, Borner U, Wartenberg M, Giger R, et al
    Diagnostic use of fine-needle aspiration cytology and core-needle biopsy in head and neck sarcomas.
    Head Neck. 2021;43:1939-1948.
    PubMed     Abstract available


  281. SABIQ F, Huang K, Patel A, Banerjee R, et al
    Novel imaging classification system of nodal disease in human papillomavirus-mediated oropharyngeal squamous cell carcinoma prognostic of patient outcomes.
    Head Neck. 2021;43:1854-1863.
    PubMed     Abstract available


  282. HENNOCQ Q, Saintigny P, Quilhot P, Bertolus C, et al
    Association between sex and survival in patients with head and neck spindle cell carcinoma.
    Head Neck. 2021;43:1864-1871.
    PubMed     Abstract available


  283. YANG J, Wei R, Song X, Sun X, et al
    Risk of second primary malignancy after minor salivary gland cancer: A Surveillance, Epidemiology, and End Results database analysis.
    Head Neck. 2021;43:1769-1779.
    PubMed     Abstract available


  284. SAMPLE RA, Wood CB, Mazul AL, Barrett TF, et al
    Low-risk human papilloma virus positive oropharyngeal cancer with one positive lymph node: Equivalent outcomes in patients treated with surgery and radiation therapy versus surgery alone.
    Head Neck. 2021;43:1759-1768.
    PubMed     Abstract available


  285. LUGINBUHL A, Kahue CN, Stewart M, Curry JM, et al
    Head and neck surgery global outreach: Ethics, planning, and impact.
    Head Neck. 2021;43:1780-1787.
    PubMed     Abstract available


  286. WANG X, Zheng X, Zhu J, Li Z, et al
    Radioactive iodine therapy may not improve disease-specific survival in follicular variant papillary thyroid cancer without distant metastasis: A propensity score-matched analysis.
    Head Neck. 2021;43:1730-1738.
    PubMed     Abstract available


  287. LANISNIK B, Levart P, Cizmarevic B, Svagan M, et al
    Surgeon-performed ultrasound with fine-needle aspiration biopsy for the diagnosis of parotid gland tumors.
    Head Neck. 2021;43:1739-1746.
    PubMed     Abstract available


  288. YAVUZ H, Vural O
    Tracheoesophageal puncture closure with annular mucosal flap.
    Head Neck. 2021;43:1705-1710.
    PubMed     Abstract available


    May 2021
  289. FAGAN JJ, Otiti J, Onakoya PA, Diom E, et al
    AfHNS fellowship: A model to improve access to head and neck cancer care in Africa and developing countries.
    Head Neck. 2021 May 29. doi: 10.1002/hed.26770.
    PubMed     Abstract available


  290. YANG S, Yuan ZJ, Zhu YH, Chen X, et al
    lncRNA PVT1 promotes cetuximab resistance of head and neck squamous cell carcinoma cells by inhibiting miR-124-3p.
    Head Neck. 2021 May 25. doi: 10.1002/hed.26742.
    PubMed     Abstract available


  291. CIVANTOS AM, Prasad A, Carey RM, Bur AM, et al
    Palliative care in metastatic head and neck cancer.
    Head Neck. 2021 May 21. doi: 10.1002/hed.26761.
    PubMed     Abstract available


  292. GOSHTASBI K, Abiri A, Lehrich BM, Haidar YM, et al
    The influence of facility volume on patient treatments and survival outcomes in nasopharyngeal carcinoma.
    Head Neck. 2021 May 17. doi: 10.1002/hed.26739.
    PubMed     Abstract available


  293. PANG J, Faraji F, Risa E, Mell LK, et al
    High rates of postoperative radiotherapy delay in head and neck cancer before and after Medicaid expansion.
    Head Neck. 2021 May 17. doi: 10.1002/hed.26736.
    PubMed     Abstract available


  294. HOESSEINI A, van Leeuwen N, Offerman MPJ, Zhang J, et al
    Predicting survival in head and neck cancer: External validation and update of the prognostic model OncologIQ in 2189 patients.
    Head Neck. 2021 May 7. doi: 10.1002/hed.26716.
    PubMed     Abstract available


  295. RIJO-CEDENO J, Mucientes J, Seijas Marcos S, Romero J, et al
    Adding value to tumor staging in head and neck cancer: The role of metabolic parameters as prognostic factors.
    Head Neck. 2021 May 6. doi: 10.1002/hed.26725.
    PubMed     Abstract available


  296. VERMAIRE JA, Terhaard CHJ, Verdonck-de Leeuw IM, Raaijmakers CPJ, et al
    Reliability of the 100 mL water swallow test in patients with head and neck cancer and healthy subjects.
    Head Neck. 2021 May 6. doi: 10.1002/hed.26723.
    PubMed     Abstract available


  297. LIAO W, He J, Gou Q, Duan B, et al
    Local treatment of metastases plus systemic chemotherapy on overall survival of patients with metastatic nasopharyngeal carcinoma.
    Head Neck. 2021 May 3. doi: 10.1002/hed.26706.
    PubMed     Abstract available


  298. CHANG JW, Lee S, Lee JM, Moon IS, et al
    Occult parotid involvement in early-stage squamous cell carcinoma of the external auditory canal.
    Head Neck. 2021 May 3. doi: 10.1002/hed.26729.
    PubMed     Abstract available


  299. DE VIRGILIO A, Kim SH, Wang CC, Holsinger FC, et al
    Anatomical-based classification for transoral base of tongue resection.
    Head Neck. 2021;43:1604-1609.
    PubMed     Abstract available


  300. OTTENSTEIN L, Cornett H, Switchenko JM, Nathan M, et al
    Characterizing postoperative physiologic swallow function following transoral robotic surgery for early stage tonsil, base of tongue, and unknown primary human papillomavirus-associated squamous cell carcinoma.
    Head Neck. 2021;43:1629-1640.
    PubMed     Abstract available


  301. DE VIRGILIO A, Costantino A, Ferreli F, Malvezzi L, et al
    High-definition three-dimensional exoscope for head and neck reconstruction: Prospective analysis of 27 consecutive patients.
    Head Neck. 2021;43:1574-1580.
    PubMed     Abstract available


  302. SUNG YE, Kim MS, Lee YS
    Proposal of a scoring system for predicting pathological risk based on a semiautomated analysis of whole slide images in oral squamous cell carcinoma.
    Head Neck. 2021;43:1581-1591.
    PubMed     Abstract available


  303. LIM Y, Tang KD, Karpe AV, Beale DJ, et al
    Chemoradiation therapy changes oral microbiome and metabolomic profiles in patients with oral cavity cancer and oropharyngeal cancer.
    Head Neck. 2021;43:1521-1534.
    PubMed     Abstract available


  304. TAM S, Gajera M, Luo X, Glisson BS, et al
    Cytotoxic and targeted systemic therapy in patients with advanced cutaneous squamous cell carcinoma in the head and neck.
    Head Neck. 2021;43:1592-1603.
    PubMed     Abstract available


  305. YOUNG A, Bigcas JL, Yang A, Reeve N, et al
    Transoral robotic submandibular gland transposition to reconstruct radical tonsillar resection defects.
    Head Neck. 2021;43:1695-1698.
    PubMed     Abstract available


  306. GUALTIERI T, Verzeletti V, Ferrari M, Perotti P, et al
    A new landmark for lingual artery identification during transoral surgery: Anatomic-radiologic study.
    Head Neck. 2021;43:1487-1498.
    PubMed     Abstract available


  307. SMITH AW, Gallitto M, Lehrer EJ, Wasserman I, et al
    Redefining risk of contralateral cervical nodal disease in early stage oropharyngeal cancer in the human papillomavirus era.
    Head Neck. 2021;43:1409-1414.
    PubMed     Abstract available


  308. MOLTENI G, Gazzini L, Sacchetto A, Nocini R, et al
    Role of the temporoparietal fascia free flap in salvage total laryngectomy.
    Head Neck. 2021;43:1692-1694.
    PubMed     Abstract available


  309. LIU HY, Daniels CP, Trada Y, Bernard A, et al
    The importance of smoking status at diagnosis in human papillomavirus-associated oropharyngeal cancer.
    Head Neck. 2021;43:1440-1450.
    PubMed     Abstract available


  310. NOCON CC, Kuchta K, Bhayani MK
    Prognostic value of lymph node ratio versus American Joint Committee on Cancer N classification for surgically resected human papillomavirus-associated oropharyngeal squamous cell carcinoma.
    Head Neck. 2021;43:1476-1486.
    PubMed     Abstract available


    April 2021
  311. XU H, Lu L, Lu T, Xu Y, et al
    Identifying the optimal candidates for locoregional radiation therapy in patients with de novo metastatic nasopharyngeal carcinoma.
    Head Neck. 2021 Apr 27. doi: 10.1002/hed.26726.
    PubMed     Abstract available


  312. HIGHLAND J, Aylward A, Do O, Monroe M, et al
    Trust in physicians among patients with head and neck cancer before and after treatment.
    Head Neck. 2021 Apr 26. doi: 10.1002/hed.26721.
    PubMed     Abstract available


  313. SEKI-SODA M, Sano T, Ogawa M, Yokoo S, et al
    CD15(+) tumor infiltrating granulocytic cells can predict recurrence and their depletion is accompanied by good responses to S-1 with oral cancer.
    Head Neck. 2021 Apr 24. doi: 10.1002/hed.26712.
    PubMed     Abstract available


  314. NUYTS S, Bollen H, Eisbruch A, Corry J, et al
    Unilateral versus bilateral nodal irradiation: Current evidence in the treatment of squamous cell carcinoma of the head and neck.
    Head Neck. 2021 Apr 19. doi: 10.1002/hed.26713.
    PubMed     Abstract available


  315. MESSING BP, Ward EC, Lazarus C, Ryniak K, et al
    Longitudinal comparisons of a whole-mouth taste test to clinician-rated and patient-reported outcomes of dysgeusia postradiotherapy in patients with head and neck cancer and associations with oral intake.
    Head Neck. 2021 Apr 15. doi: 10.1002/hed.26690.
    PubMed     Abstract available


  316. WANG SM, Yin SC, Su XZ, Xu Q, et al
    Magnitude of radial forearm free flaps and factors associated with loss of volume in oral cancer reconstructive surgery: A prospective study.
    Head Neck. 2021 Apr 13. doi: 10.1002/hed.26704.
    PubMed     Abstract available


  317. WIBONELE BK, Smith BD, Altonji S, Kaplan S, et al
    Head and neck cancer research collaborations between the United States and low- and middle-income countries: A 10-year publication analysis.
    Head Neck. 2021 Apr 5. doi: 10.1002/hed.26703.
    PubMed     Abstract available


  318. YANG N, Mercier E, Guertin L, Bissada E, et al
    Development, translation, and preliminary validation of the neck dissection assessment tool.
    Head Neck. 2021 Apr 2. doi: 10.1002/hed.26696.
    PubMed     Abstract available


  319. SMITS HJG, Assili S, Kauw F, Philippens MEP, et al
    Prognostic imaging variables for recurrent laryngeal and hypopharyngeal carcinoma treated with primary chemoradiotherapy: A systematic and meta-analysis.
    Head Neck. 2021 Apr 2. doi: 10.1002/hed.26698.
    PubMed     Abstract available


  320. ZAKERI K, Wang H, Kang JJ, Lee A, et al
    Outcomes and prognostic factors of major salivary gland tumors treated with proton beam radiation therapy.
    Head Neck. 2021;43:1056-1062.
    PubMed     Abstract available


  321. SCHVARTSMAN G, Bell D, Rubin ML, Tetzlaff M, et al
    The tumor immune contexture of salivary duct carcinoma.
    Head Neck. 2021;43:1213-1219.
    PubMed     Abstract available


  322. XING MH, Mundi N, Govindan A, Khorsandi A, et al
    Unusual location of a second branchial cleft cyst presenting in the suprasternal notch.
    Head Neck. 2021;43:E27-E29.
    PubMed     Abstract available


  323. BALASUBRAMANIAN D, Subramaniam N, Missale F, Marchi F, et al
    Predictive nomograms for oral tongue squamous cell carcinoma applying the American Joint Committee on Cancer/Union Internationale Contre le Cancer 8th edition staging system.
    Head Neck. 2021;43:1043-1055.
    PubMed     Abstract available


  324. DONG P, Wang L, Qu Y, Huang R, et al
    Low- and high-dose radioiodine ablation for low-/intermediate-risk differentiated thyroid cancer in China: Large randomized clinical trial.
    Head Neck. 2021;43:1311-1320.
    PubMed     Abstract available


  325. MASHRAH MA, Aldhohrah T, Abdelrehem A, Koraitim M, et al
    What is the best method for prevention of postparotidectomy Frey syndrome? Network meta-analysis.
    Head Neck. 2021;43:1345-1358.
    PubMed     Abstract available


  326. STACK BC JR, Twining C, Rastatter J, Angelos P, et al
    Consensus statement by the American Association of Clinical Endocrinology (AACE) and the American Head and Neck Society Endocrine Surgery Section (AHNS-ES) on Pediatric Benign and Malignant Thyroid Surgery.
    Head Neck. 2021;43:1027-1042.
    PubMed     Abstract available


  327. ATALLAH I, Castellanos PF
    Transoral closure of the supraglottic larynx for intractable aspiration.
    Head Neck. 2021;43:1370-1375.
    PubMed     Abstract available


  328. SINHA S, Agarwal JP, Mahajan A, Chaturvedi P, et al
    Implications of limited exolaryngeal disease and cricoarytenoid joint involvement in organ conservation protocols for laryngopharyngeal cancers: Results from a prospective study.
    Head Neck. 2021;43:1289-1299.
    PubMed     Abstract available


  329. MCKENZIE RM, Parhar HS, Ng TL, Prisman E, et al
    Muscle invasion in oropharyngeal carcinoma undergoing transoral robotic surgery.
    Head Neck. 2021;43:1194-1201.
    PubMed     Abstract available


  330. CAREY RM, Shimunov D, Weinstein GS, Cannady SB, et al
    Increased rate of recurrence and high rate of salvage in patients with human papillomavirus-associated oropharyngeal squamous cell carcinoma with adverse features treated with primary surgery without recommended adjuvant therapy.
    Head Neck. 2021;43:1128-1141.
    PubMed     Abstract available


  331. LIU WC, Liu HE, Kao YW, Qin L, et al
    Definitive intensity-modulated radiotherapy or surgery for early oral cavity squamous cell carcinoma: Propensity-score-matched, nationwide, population-based cohort study.
    Head Neck. 2021;43:1142-1152.
    PubMed     Abstract available


  332. SUN M, Wang K, Qu Y, Zhang J, et al
    Proposal of a TNM classification-based staging system for esthesioneuroblastoma: More precise prediction of prognosis.
    Head Neck. 2021;43:1097-1104.
    PubMed     Abstract available


  333. KUMAR A, Laskar SG, Thiagarajan S
    Is Transoral Robotic Surgery (TORS) for oropharyngeal squamous cell carcinoma being done more often than actually indicated?
    Head Neck. 2021;43:1376-1377.
    PubMed    


  334. BATES JE, Amdur RJ
    In reply to Kumar et al, Is TORS for oropharyngeal squamous cell carcinoma being done more often than actually indicated?
    Head Neck. 2021;43:1378-1379.
    PubMed    


  335. ROOKER SA, Van Abel KM, Yin LX, Nagelschneider AA, et al
    Risk factors for subsequent recurrence after surgical treatment of recurrent pleomorphic adenoma of the parotid gland.
    Head Neck. 2021;43:1088-1096.
    PubMed     Abstract available


  336. SARI SY, Yilmaz MT, Elmali A, Yedekci FY, et al
    Parotid gland stem cells: Mini yet mighty.
    Head Neck. 2021;43:1122-1127.
    PubMed     Abstract available


    March 2021
  337. GUAN H, He Y, Su Y, Wei Z, et al
    Assessment of different induction chemotherapy regimens in locally advanced nasopharyngeal carcinoma: A meta-analysis.
    Head Neck. 2021 Mar 31. doi: 10.1002/hed.26699.
    PubMed     Abstract available


  338. LI W, Lu H, Wang H, Hu L, et al
    Establishment and validation of a novel nomogram to predict overall survival in nasopharyngeal carcinoma with lymph node metastasis.
    Head Neck. 2021 Mar 29. doi: 10.1002/hed.26687.
    PubMed     Abstract available


  339. NG WT, Tsang RKY, Beitler JJ, de Bree R, et al
    Contemporary management of the neck in nasopharyngeal carcinoma.
    Head Neck. 2021 Mar 29. doi: 10.1002/hed.26685.
    PubMed     Abstract available


  340. EBERSOLE B, McCarroll L, Ridge JA, Liu JC, et al
    Identification and management of late dysfunction in survivors of head and neck cancer: Implementation and outcomes of an interdisciplinary quality of life (IQOL) clinic.
    Head Neck. 2021 Mar 21. doi: 10.1002/hed.26681.
    PubMed     Abstract available


  341. STADLER TM, Morand GB, Rupp NJ, Hullner MW, et al
    FDG-PET-CT/MRI in head and neck squamous cell carcinoma: Impact on pretherapeutic N classification, detection of distant metastases, and second primary tumors.
    Head Neck. 2021 Mar 17. doi: 10.1002/hed.26668.
    PubMed     Abstract available


  342. SHAH R, Gosavi V, Mahajan A, Sonawane S, et al
    Preoperative prediction of parathyroid carcinoma in an Asian Indian cohort.
    Head Neck. 2021 Mar 10. doi: 10.1002/hed.26677.
    PubMed     Abstract available


  343. PATEL U, Mittal N, Rane SU, Patil A, et al
    Correlation of transcriptionally active human papillomavirus status with the clinical and molecular profiles of head and neck squamous cell carcinomas.
    Head Neck. 2021 Mar 10. doi: 10.1002/hed.26676.
    PubMed     Abstract available


  344. SAKA-HERRAN C, Jane-Salas E, Estrugo-Devesa A, Lopez-Lopez J, et al
    Head and neck cancer and non-steroidal anti-inflammatory drugs: Systematic review and meta-analysis.
    Head Neck. 2021 Mar 8. doi: 10.1002/hed.26663.
    PubMed     Abstract available


  345. SANSA A, Venegas MDP, Valero C, Pardo L, et al
    The aspartate aminotransaminase/alanine aminotransaminase (De Ritis) ratio predicts sensitivity to radiotherapy in head and neck carcinoma patients.
    Head Neck. 2021 Mar 6. doi: 10.1002/hed.26673.
    PubMed     Abstract available


  346. FASSAS S, Cummings E, Sykes KJ, Bur AM, et al
    Telemedicine for head and neck cancer surveillance in the COVID-19 era: Promise and pitfalls.
    Head Neck. 2021 Mar 4. doi: 10.1002/hed.26659.
    PubMed     Abstract available


  347. WARREN EAK, Anil J, Castro PD, Kemnade J, et al
    Human epidermal growth factor receptor 2 expression in head and neck squamous cell carcinoma: Variation within and across primary tumor sites, and implications for antigen-specific immunotherapy.
    Head Neck. 2021 Mar 4. doi: 10.1002/hed.26662.
    PubMed     Abstract available


  348. BUGTER O, van Iwaarden DLP, van Leeuwen N, Nieboer D, et al
    A cause-specific Cox model for second primary tumors in patients with head and neck cancer: A RONCDOC study.
    Head Neck. 2021 Mar 3. doi: 10.1002/hed.26666.
    PubMed     Abstract available


  349. KIONG KL, Diaz EM, Gross ND, Diaz EM Jr, et al
    The impact of COVID-19 on head and neck cancer diagnosis and disease extent.
    Head Neck. 2021 Mar 2. doi: 10.1002/hed.26665.
    PubMed     Abstract available


  350. DICKSTEIN DR, Egerman M, Monrose E, Varma A, et al
    Treatment tolerability and outcomes in elderly patients with head and neck cancer.
    Head Neck. 2021;43:858-873.
    PubMed     Abstract available


  351. TODSEN T, Bennedbaek FN, Kiss K, Hegedus L, et al
    Ultrasound-guided fine-needle aspiration biopsy of thyroid nodules.
    Head Neck. 2021;43:1009-1013.
    PubMed     Abstract available


  352. DAVIES L
    Why are there different conclusions about thyroid cancer mortality?
    Head Neck. 2021;43:984-986.
    PubMed    


  353. LABARGE B, Walter V, Bann DV, Goldenberg D, et al
    In-depth analysis of thyroid cancer mortality.
    Head Neck. 2021;43:977-983.
    PubMed     Abstract available


  354. LYU X, Liu S, Zheng L, Huang M, et al
    New approach to an overlooked flap: Technique to augment venous drainage of the infrahyoid myocutaneous flap.
    Head Neck. 2021;43:942-948.
    PubMed     Abstract available


  355. COLAIANNI CA, Feng AL, Richmon JD
    Partial parotidectomy via periauricular incision: Retrospective cohort study and comparative analysis to alternative incisional approaches.
    Head Neck. 2021;43:825-832.
    PubMed     Abstract available


  356. GUNTINAS-LICHIUS O, Thielker J, Robbins KT, Olsen KD, et al
    Prognostic role of intraparotid lymph node metastasis in primary parotid cancer: Systematic review.
    Head Neck. 2021;43:997-1008.
    PubMed     Abstract available


  357. DOESCHER J, Minkenberg P, Laban S, Kostezka U, et al
    Immune checkpoint expression in HNSCC patients before and after definitive chemoradiotherapy.
    Head Neck. 2021;43:778-787.
    PubMed     Abstract available


  358. SWARTZ JE, Wegner I, Noorlag R, van Kempen PMW, et al
    HIF-1a expression and differential effects on survival in patients with oral cavity, larynx, and oropharynx squamous cell carcinomas.
    Head Neck. 2021;43:745-756.
    PubMed     Abstract available


  359. SULLIVAN CB, Al-Qurayshi Z, Chang K, Pagedar NA, et al
    Analysis of palliative care treatment among head and neck patients with cancer: National perspective.
    Head Neck. 2021;43:805-815.
    PubMed     Abstract available


    February 2021
  360. LI M, Zhang B, Chen Q, Zhang L, et al
    Concurrent chemoradiotherapy with additional chemotherapy for nasopharyngeal carcinoma: A pooled analysis of propensity score-matching studies.
    Head Neck. 2021 Feb 28. doi: 10.1002/hed.26664.
    PubMed     Abstract available


  361. STEPAN KO, Mazul AL, Skillington SA, Paniello RC, et al
    The prognostic significance of race in nasopharyngeal carcinoma by histological subtype.
    Head Neck. 2021 Feb 23. doi: 10.1002/hed.26639.
    PubMed     Abstract available


  362. YANG K, Li M, Zhu J, Zeng L, et al
    Nomograms for predicting survival outcomes in intensity-modulated radiotherapy era of nasopharyngeal carcinoma: A study based on Epstein-Barr virus DNA biological responses.
    Head Neck. 2021 Feb 19. doi: 10.1002/hed.26654.
    PubMed     Abstract available


  363. VAN DER LANS RJL, Engel MSD, Rijken JA, Hensen EF, et al
    Neuroendocrine neoplasms of the middle ear: Unpredictable tumor behavior and tendency for recurrence.
    Head Neck. 2021 Feb 19. doi: 10.1002/hed.26658.
    PubMed     Abstract available


  364. RAMSEY T, Lee B, Curran K, Desai V, et al
    Associations of insurance, urbanity, and comorbidity with types of palliative care received by patients with head and neck cancer.
    Head Neck. 2021 Feb 18. doi: 10.1002/hed.26648.
    PubMed     Abstract available


  365. RANGABASHYAM M, Koh SQ, Sultana R, Tan NC, et al
    Factors associated with returning to work in head and neck cancer survivors in Singapore: A preliminary exploratory mixed-methods approach study.
    Head Neck. 2021 Feb 18. doi: 10.1002/hed.26644.
    PubMed     Abstract available


  366. FUNG SYH, Chan KCA, Wong EWY, Ng CWK, et al
    Droplet digital PCR of tumor suppressor gene methylation in serial oral rinses of patients with head and neck squamous cell carcinoma.
    Head Neck. 2021 Feb 17. doi: 10.1002/hed.26647.
    PubMed     Abstract available


  367. SABOUR S, Ghajari H
    Diagnostic value of exosomal circMYC in radioresistant nasopharyngeal carcinoma: Methodological issues.
    Head Neck. 2021 Feb 17. doi: 10.1002/hed.26645.
    PubMed    


  368. ELSHARAWI R, Antonucci E, Sukari A, Cramer JD, et al
    Quality metrics for head and neck cancer treated with definitive radiotherapy and/or chemotherapy.
    Head Neck. 2021 Feb 17. doi: 10.1002/hed.26640.
    PubMed     Abstract available


  369. GUO J, Gui R
    Reply: Diagnostic value of exosomal circMYC in radioresistant nasopharyngeal carcinoma: Methodological issues (HED-20-22881).
    Head Neck. 2021 Feb 17. doi: 10.1002/hed.26652.
    PubMed    


  370. USHINSKY A, Guevara CJ, Kim SK
    Intranodal lymphangiography with thoracic duct embolization for the treatment of chyle leaks after head and neck cancer surgery.
    Head Neck. 2021 Feb 15. doi: 10.1002/hed.26646.
    PubMed     Abstract available


  371. GRECO E, Ringash J, Tomlinson G, Huang SH, et al
    Presence and duration of feeding tube in a 5-year cohort of patients with head and neck cancer treated with curative intensity-modulated radiation therapy.
    Head Neck. 2021 Feb 13. doi: 10.1002/hed.26638.
    PubMed     Abstract available


  372. BURGIN SJM, Spector ME, Pearson AT, Bellile E, et al
    Long-term neck and shoulder function among survivors of oropharyngeal squamous cell carcinoma treated with chemoradiation as assessed with the neck dissection impairment index.
    Head Neck. 2021 Feb 12. doi: 10.1002/hed.26636.
    PubMed     Abstract available


  373. POON DMC, Kam MKM, Johnson D, Mo F, et al
    Durability of the parotid-sparing effect of intensity-modulated radiotherapy (IMRT) in early stage nasopharyngeal carcinoma: A 15-year follow-up of a randomized prospective study of IMRT versus two-dimensional radiotherapy.
    Head Neck. 2021 Feb 11. doi: 10.1002/hed.26634.
    PubMed     Abstract available


  374. ANG MK, Montoya JE, Tharavichitkul E, Lim C, et al
    A phase II study of nimotuzumab (TheraCim-hR3) concurrent with cisplatin/radiotherapy in patients with locally advanced head and neck squamous cell carcinoma.
    Head Neck. 2021 Feb 5. doi: 10.1002/hed.26635.
    PubMed     Abstract available


  375. XIE G, Zhu A, Gu X
    Mitogen-activated protein kinase inhibition-induced modulation of epidermal growth factor receptor signaling in human head and neck squamous cell carcinoma.
    Head Neck. 2021 Feb 3. doi: 10.1002/hed.26633.
    PubMed     Abstract available


  376. WAI KC, Xu MJ, Lee RH, El-Sayed IH, et al
    Head and neck surgery during the coronavirus-19 pandemic: The University of California San Francisco experience.
    Head Neck. 2021;43:622-629.
    PubMed     Abstract available


  377. ALVES LDB, Menezes ACS, Pereira DL, Santos MTC, et al
    Benefits of intraoral stents in patients with head and neck cancer undergoing radiotherapy: Systematic review.
    Head Neck. 2021 Feb 1. doi: 10.1002/hed.26620.
    PubMed     Abstract available


  378. HOLCOMB AJ, Richmon JD
    Transoral robotic salvage oropharyngectomy with submental artery island flap reconstruction.
    Head Neck. 2021;43:E13-E19.
    PubMed     Abstract available


  379. DE VIRGILIO A, Costantino A, Canzano F, Accorona R, et al
    Regional disease control in sinonasal mucosal melanoma: Systematic review and meta-analysis.
    Head Neck. 2021;43:705-715.
    PubMed     Abstract available


  380. REED R, Strumpf A, Martz TG, Kavanagh KJ, et al
    2015 American Thyroid Association guidelines and thyroid-stimulating hormone suppression after thyroid lobectomy.
    Head Neck. 2021;43:639-644.
    PubMed     Abstract available


  381. LUK PP, Ebrahimi A, Veness MJ, McDowell L, et al
    Prognostic value of the 8th edition American Joint Commission Cancer nodal staging system for patients with head and neck cutaneous squamous cell carcinoma: A multi-institutional study.
    Head Neck. 2021;43:558-567.
    PubMed     Abstract available


  382. LAO WP, Lagabon KJ, Arom GA, Walker PC, et al
    Combined endoscopic and transoral resection of a high-staged juvenile nasopharyngeal angiofibroma: A pictorial essay.
    Head Neck. 2021;43:719-724.
    PubMed     Abstract available


  383. BINZ GHA, Soyka MB, Holzmann D, Meerwein CM, et al
    Need for long-term follow-up in sinonasal inverted papilloma: A Single-institution experience.
    Head Neck. 2021;43:630-638.
    PubMed     Abstract available


  384. SMITHERS FAE, Haymerle G, Palme CE, Low TH, et al
    A prospective study of intraoperative assessment of mucosal squamous cell carcinoma margins in the head and neck.
    Head Neck. 2021;43:590-600.
    PubMed     Abstract available


  385. HUM L, Bethmann D, Feng Z, Chang SC, et al
    Cumulative suppressive index as a predictor of relapse free survival and overall survival in Human Papilloma Virus-negative oral squamous cell carcinomas with negative resection margins.
    Head Neck. 2021;43:568-576.
    PubMed     Abstract available


  386. PINATTI LM, Sinha HN, Brummel CV, Goudsmit CM, et al
    Association of human papillomavirus integration with better patient outcomes in oropharyngeal squamous cell carcinoma.
    Head Neck. 2021;43:544-557.
    PubMed     Abstract available


  387. HUANG SH, de Almeida JR, Watson E, Glogauer M, et al
    Short-term and long-term unstimulated saliva flow following unilateral vs bilateral radiotherapy for oropharyngeal carcinoma.
    Head Neck. 2021;43:456-466.
    PubMed     Abstract available


  388. SU WW, Lee YH, Yen AM, Chen SL, et al
    Impact of treatment delay on survival of oral/oropharyngeal cancers: Results of a nationwide screening program.
    Head Neck. 2021;43:473-484.
    PubMed     Abstract available


  389. YIN LX, Van Abel KM, Rooker SA, Nagelschneider AA, et al
    Risk factors for carcinoma ex pleomorphic adenoma in patients presenting with recurrence after resection of pleomorphic adenoma.
    Head Neck. 2021;43:419-427.
    PubMed     Abstract available


  390. BOS P, van den Brekel MWM, Gouw ZAR, Al-Mamgani A, et al
    Clinical variables and magnetic resonance imaging-based radiomics predict human papillomavirus status of oropharyngeal cancer.
    Head Neck. 2021;43:485-495.
    PubMed     Abstract available


  391. KIKUCHI M, Yamashita D, Hara S, Takebayashi S, et al
    Clinical significance of tumor-associated immune cells in patients with oral squamous cell carcinoma.
    Head Neck. 2021;43:534-543.
    PubMed     Abstract available


  392. ARUN I, Maity N, Hameed S, Jain PV, et al
    Lymph node characteristics and their prognostic significance in oral squamous cell carcinoma.
    Head Neck. 2021;43:520-533.
    PubMed     Abstract available


  393. BASIM P, Argun D, Ozdenkaya Y
    Self-reported medication adherence in differentiated thyroid cancer survivors: Role of illness perception and medication beliefs.
    Head Neck. 2021;43:428-437.
    PubMed     Abstract available


    January 2021
  394. GISSI DB, Morandi L, Colella G, De Luca R, et al
    Clinical validation of 13-gene DNA methylation analysis in oral brushing samples for detection of oral carcinoma: An Italian multicenter study.
    Head Neck. 2021 Jan 28. doi: 10.1002/hed.26624.
    PubMed     Abstract available


  395. HOPKINS-ROSSABI T, Armeson KE, Zecker SG, Martin-Harris B, et al
    Respiratory-swallow coordination and swallowing impairment in head and neck cancer.
    Head Neck. 2021 Jan 25. doi: 10.1002/hed.26609.
    PubMed     Abstract available


  396. IQBAL MS, Kelly C, Kovarik J, McQueen A, et al
    Rapid recurrence in postoperative head and neck cancer: Underappreciated or overcalled problem?
    Head Neck. 2021 Jan 25. doi: 10.1002/hed.26615.
    PubMed    


  397. POLCE S, Gogineni E, Antone J, Ghaly M, et al
    Dental radiation dosimetric maps from intensity-modulated radiation therapy planning for head and neck cancers.
    Head Neck. 2021 Jan 15. doi: 10.1002/hed.26611.
    PubMed     Abstract available


  398. WEI ZG, Hu XL, He Y, Guan H, et al
    Clinical and survival analysis of nasopharyngeal carcinoma with consistently negative Epstein-Barr virus DNA.
    Head Neck. 2021 Jan 9. doi: 10.1002/hed.26608.
    PubMed     Abstract available


  399. MAYS AC, Yarlagadda B, Achim V, Jackson R, et al
    Examining the relationship of immunotherapy and wound complications following flap reconstruction in patients with head and neck cancer.
    Head Neck. 2021 Jan 8. doi: 10.1002/hed.26601.
    PubMed     Abstract available


  400. INGARFIELD K, McMahon AD, Hurley K, Toms S, et al
    Inequality in survival of people with head and neck cancer: Head and Neck 5000 cohort study.
    Head Neck. 2021 Jan 8. doi: 10.1002/hed.26589.
    PubMed     Abstract available


  401. BROEMER L, Friedrich M, Wichmann G, Muller J, et al
    Exploratory study of functional and psychological factors associated with employment status in patients with head and neck cancer.
    Head Neck. 2021 Jan 1. doi: 10.1002/hed.26595.
    PubMed     Abstract available


  402. JOZAGHI Y, Zafereo M, Williams MD, Gule-Monroe MK, et al
    Neoadjuvant selpercatinib for advanced medullary thyroid cancer.
    Head Neck. 2021;43:E7-E12.
    PubMed     Abstract available


  403. WANG Y, Zhou S, Liu X, Rui S, et al
    Transoral endoscopic thyroidectomy vestibular approach vs conventional open thyroidectomy: Meta-analysis.
    Head Neck. 2021;43:345-353.
    PubMed     Abstract available


  404. HAYDEN RE, Chang BA, Mullin DP, Patel AK, et al
    Bipedicled submental musculofascial "hammock" flap for salvage laryngectomy closure reinforcement.
    Head Neck. 2021;43:198-202.
    PubMed     Abstract available


  405. PATEL KB, Martin D, Zhao S, Kumar B, et al
    Impact of age and comorbidity on survival among patients with oral cavity squamous cell carcinoma.
    Head Neck. 2021;43:268-277.
    PubMed     Abstract available


  406. SHARBEL DD, Abkemeier M, Sullivan J, Zimmerman Z, et al
    Transcervical arterial ligation for prevention of postoperative hemorrhage in transoral oropharyngectomy: Systematic review and meta-analysis.
    Head Neck. 2021;43:334-344.
    PubMed     Abstract available


  407. MOORE EJ, Van Abel KM, Routman DM, Lohse CM, et al
    Human papillomavirus oropharynx carcinoma: Aggressive de-escalation of adjuvant therapy.
    Head Neck. 2021;43:229-237.
    PubMed     Abstract available


  408. CLARK CM, Newark AC, Fokar A, Maxwell JH, et al
    Aspirin use predicts prolonged survival in patients with oropharyngeal cancer: Nationwide Veterans Affairs database study.
    Head Neck. 2021;43:247-254.
    PubMed     Abstract available


  409. FUNG AS, Afzal AR, Banerjee R, Debenham B, et al
    A real-world comparison of cisplatin vs cetuximab used concurrently with radiation in the treatment of locally advanced oropharyngeal carcinoma.
    Head Neck. 2021;43:153-163.
    PubMed     Abstract available


  410. PANUGANTI BA, Stuart E, Weissbrod P
    Changes in treatment trends in the early glottic cancer population after the Affordable Care Act.
    Head Neck. 2021;43:137-144.
    PubMed     Abstract available


  411. CHWEYA CM, Low CM, Van Gompel JJ, Van Abel KM, et al
    Population-based analysis on the effect of nodal and distant metastases in sinonasal adenocarcinoma.
    Head Neck. 2021;43:128-136.
    PubMed     Abstract available


  412. GRANT-FREEMANTLE MC, Lane O'Neill B, Clover AJP
    The effectiveness of radiotherapy in the treatment of head and neck mucosal melanoma: Systematic review and meta-analysis.
    Head Neck. 2021;43:323-333.
    PubMed     Abstract available


  413. LIU SW, Woody NM, Wei W, Appachi S, et al
    Evaluating compliance with process-related quality metrics and survival in oral cavity squamous cell carcinoma: Multi-institutional oral cavity collaboration study.
    Head Neck. 2021;43:60-69.
    PubMed     Abstract available


  414. ZEVALLOS JP, Kramer JR, Sandulache VC, Massa ST, et al
    National trends in oropharyngeal cancer incidence and survival within the Veterans Affairs Health Care System.
    Head Neck. 2021;43:108-115.
    PubMed     Abstract available


  415. YAN F, Desiato VM, Nguyen SA, Lentsch EJ, et al
    Impact of greater auricular nerve sacrifice during parotidectomy on quality of life.
    Head Neck. 2021;43:70-78.
    PubMed     Abstract available


    December 2020
  416. PANDIT PN, Patil RA, Palwe VS, Tambade SH, et al
    Patterns of blood pressure changes in patients with head and neck cancer receiving radiotherapy or chemo-radiotherapy at a tertiary cancer centre.
    Head Neck. 2020 Dec 29. doi: 10.1002/hed.26590.
    PubMed     Abstract available


  417. FANG R, Peng L, Chen L, Liao J, et al
    The survival benefit of lymph node dissection in resected T1-2, cN0 supraglottic cancer: A population-based propensity score matching analysis.
    Head Neck. 2020 Dec 29. doi: 10.1002/hed.26596.
    PubMed     Abstract available


  418. STARR N, Oyler DR, Schadler A, Aouad RK, et al
    Chronic opioid use after laryngeal cancer treatment.
    Head Neck. 2020 Dec 28. doi: 10.1002/hed.26591.
    PubMed     Abstract available


  419. RAO VUS, Subash A, R Bhargavi V, Sinha P, et al
    Selective embolization of lingual artery in transoral robotic surgery for the management of recurrent base of tongue carcinomas.
    Head Neck. 2020 Dec 24. doi: 10.1002/hed.26585.
    PubMed     Abstract available


  420. KISHIKAWA T, Suzuki M, Takemoto N, Fukusumi T, et al
    Response Evaluation Criteria in Solid Tumors (RECIST) and PET Response Criteria in Solid Tumors (PERCIST) for response evaluation of the neck after chemoradiotherapy in head and neck squamous cell carcinoma.
    Head Neck. 2020 Dec 23. doi: 10.1002/hed.26583.
    PubMed     Abstract available


  421. GARCIA-ANAYA MJ, Ordonez R, Toledo MD, Correa RC, et al
    Importance of dose in palliative treatment for incurable head and neck cancer with radiotherapy.
    Head Neck. 2020 Dec 15. doi: 10.1002/hed.26555.
    PubMed     Abstract available


  422. ANDERSON EM, Luu M, Balzer BL, Scher KS, et al
    Variations in the association of grade with survival across the head and neck cancer landscape.
    Head Neck. 2020 Dec 10. doi: 10.1002/hed.26566.
    PubMed     Abstract available


  423. CHEN G, Jiang H, Jiang D, Wu Q, et al
    Pretreatment serum vitamin level predicts severity of radiation-induced oral mucositis in patients with nasopharyngeal carcinoma.
    Head Neck. 2020 Dec 10. doi: 10.1002/hed.26576.
    PubMed     Abstract available


  424. SANDLER ML, Xing MH, Levy JC, Chai RL, et al
    Metastatic thyroid carcinoma to the parapharyngeal and retropharyngeal spaces: Systematic review with seven newly reported cases describing an uncommon presentation of a common disease.
    Head Neck. 2020 Dec 9. doi: 10.1002/hed.26572.
    PubMed     Abstract available


  425. CARNABY GD, Chhabria K
    Preliminary development and validation of a measure of fear of swallowing and swallowing-related movement injury in head and neck cancer: Swallowing Kinesiophobia Scale.
    Head Neck. 2020 Dec 2. doi: 10.1002/hed.26573.
    PubMed     Abstract available


  426. WORKMAN AD, Soylu S, Kamani D, Nourmahnad A, et al
    Limitations of preoperative cytology for medullary thyroid cancer: Proposal for improved preoperative diagnosis for optimal initial medullary thyroid carcinoma specific surgery.
    Head Neck. 2020 Dec 2. doi: 10.1002/hed.26550.
    PubMed     Abstract available


    November 2020
  427. YI X, Chen W, Li C, Chen X, et al
    Circular RNA circ_0004507 contributes to laryngeal cancer progression and cisplatin resistance by sponging miR-873 to upregulate multidrug resistance 1 and multidrug resistance protein 1.
    Head Neck. 2020 Nov 28. doi: 10.1002/hed.26549.
    PubMed     Abstract available


  428. ZHANG Z, Xia F, Wang W, Jiang B, et al
    Ambulatory thyroidectomy is safe and beneficial in papillary thyroid carcinoma: Randomized controlled trial.
    Head Neck. 2020 Nov 28. doi: 10.1002/hed.26557.
    PubMed     Abstract available


  429. RITTER A, Badir S, Mansour M, Segal Z, et al
    Solid organ transplantation worsens the prognosis of patients with cutaneous squamous cell carcinoma of the head and neck region-Comparison between solid organ transplant recipients and immunocompetent patients.
    Head Neck. 2020 Nov 27. doi: 10.1002/hed.26546.
    PubMed     Abstract available


  430. AKALI NR, Buggaveeti R, Sukumaran SV, Balasubramanian D, et al
    Prior chemoradiotherapy and pathological perineural invasion predict the survival outcomes of salvage surgery in head and neck squamous cell carcinoma.
    Head Neck. 2020 Nov 21. doi: 10.1002/hed.26547.
    PubMed     Abstract available


  431. JURICA JM, Rubio F, Hernandez DJ, Sandulache VC, et al
    Institutional financial toxicity of failure to adhere to treatment guidelines for head and neck squamous cell carcinoma.
    Head Neck. 2020 Nov 9. doi: 10.1002/hed.26539.
    PubMed     Abstract available


  432. CARRON J, Torricelli C, Silva JK, Queiroz GSR, et al
    microRNAs deregulation in head and neck squamous cell carcinoma.
    Head Neck. 2020 Nov 6. doi: 10.1002/hed.26533.
    PubMed     Abstract available


  433. ADEOYE J, Wan CCJ, Thomson P
    Mock clinical testing in the validation of fluid-phase biomarkers for head and neck carcinoma diagnosis: A Scoping review.
    Head Neck. 2020 Nov 5. doi: 10.1002/hed.26526.
    PubMed     Abstract available


  434. YUAN X, Zhang L, Huang Y, Liu D, et al
    Induction of interleukin-6 by irradiation and its role in epithelial mesenchymal transition and radioresistance of nasopharyngeal carcinoma cells.
    Head Neck. 2020 Nov 5. doi: 10.1002/hed.26531.
    PubMed     Abstract available


  435. HU CY, Wang WM, Chu XH, Ren ZH, et al
    Global, regional, and national burden of nasopharyngeal carcinoma from 1990 to 2017-Results from the Global Burden of Disease Study 2017.
    Head Neck. 2020;42:3243-3252.
    PubMed     Abstract available


  436. GEORGE A, Bagadia RK, Joshna BM, Subash A, et al
    Soft tissue deposits: Surrogate marker for distant metastasis?
    Head Neck. 2020;42:3465-3466.
    PubMed    


    October 2020
  437. MOSES LE, Oliver JR, Rotsides JM, Shao Q, et al
    Nodal disease burden and outcome of medullary thyroid carcinoma.
    Head Neck. 2020 Oct 27. doi: 10.1002/hed.26511.
    PubMed     Abstract available


  438. CAVALIERI S, De Cecco L, Brakenhoff RH, Serafini MS, et al
    Development of a multiomics database for personalized prognostic forecasting in head and neck cancer: The Big Data to Decide EU Project.
    Head Neck. 2020 Oct 27. doi: 10.1002/hed.26515.
    PubMed     Abstract available


  439. LIU W, Qdaisat A, Zhou S, Fuller CD, et al
    Hypomagnesemia and incidence of osteoradionecrosis in patients with head and neck cancers.
    Head Neck. 2020 Oct 23. doi: 10.1002/hed.26510.
    PubMed     Abstract available


  440. MULDER FJ, Pierssens DDCG, Baijens LWJ, Kremer B, et al
    Evidence for different molecular parameters in head and neck squamous cell carcinoma of nonsmokers and nondrinkers: Systematic review and meta-analysis on HPV, p16, and TP53.
    Head Neck. 2020 Oct 23. doi: 10.1002/hed.26513.
    PubMed     Abstract available


  441. MARGALIT DN, Sacco AG, Cooper JS, Ridge JA, et al
    Systematic review of postoperative therapy for resected squamous cell carcinoma of the head and neck: Executive summary of the American Radium Society appropriate use criteria.
    Head Neck. 2020 Oct 23. doi: 10.1002/hed.26490.
    PubMed     Abstract available


  442. KONO M, Wakisaka R, Kumai T, Hayashi R, et al
    Effects of early nutritional intervention by a nutritional support team for patients with head and neck cancer undergoing chemoradiotherapy or radiotherapy.
    Head Neck. 2020 Oct 5. doi: 10.1002/hed.26502.
    PubMed     Abstract available


  443. GADKAREE SK, McCarty JC, Feng AL, Siu JM, et al
    Role of physician density in predicting stage and survival for head and neck squamous cell carcinoma.
    Head Neck. 2020 Oct 4. doi: 10.1002/hed.26495.
    PubMed     Abstract available


  444. WANG Z, Yuan H, Huang J, Hu D, et al
    Prognostic value of immune-related genes and immune cell infiltration analysis in the tumor microenvironment of head and neck squamous cell carcinoma.
    Head Neck. 2020 Oct 3. doi: 10.1002/hed.26474.
    PubMed     Abstract available


  445. OKANO W, Hayashi R, Matsuura K, Shinozaki T, et al
    Extent of salvage neck dissection following chemoradiation for locally advanced head and neck cancer.
    Head Neck. 2020 Oct 1. doi: 10.1002/hed.26494.
    PubMed     Abstract available


  446. KARATAS OF, Capik O, Barlak N, Aydin Karatas E, et al
    Comprehensive in silico analysis for identification of novel candidate target genes, including DHX36, OPA1, and SENP2, located on chromosome 3q in head and neck cancers.
    Head Neck. 2020 Oct 1. doi: 10.1002/hed.26493.
    PubMed     Abstract available


  447. JEANS C, Ward EC, Brown B, Vertigan AE, et al
    Association between external and internal lymphedema and chronic dysphagia following head and neck cancer treatment.
    Head Neck. 2020 Oct 1. doi: 10.1002/hed.26484.
    PubMed     Abstract available


  448. SYKES KJ, Morrow E, Smith JB, Holcomb AJ, et al
    What is the hold up?-Mixed-methods analysis of postoperative radiotherapy delay in head and neck cancer.
    Head Neck. 2020;42:2948-2957.
    PubMed     Abstract available


    September 2020
  449. SVAJDOVA M, Dubinsky P, Kazda T
    Radical external beam re-irradiation in the treatment of recurrent head and neck cancer: Critical review.
    Head Neck. 2020 Sep 30. doi: 10.1002/hed.26485.
    PubMed     Abstract available


  450. BRENNAN MT, Treister NS, Sollecito TP, Schmidt BL, et al
    Epidemiologic factors in patients with advanced head and neck cancer treated with radiation therapy.
    Head Neck. 2020 Sep 29. doi: 10.1002/hed.26468.
    PubMed     Abstract available


  451. LEE DY, Abraham J, Ross E, Ridge JA, et al
    Rapid recurrence in head and neck cancer: Underappreciated problem with poor outcome.
    Head Neck. 2020 Sep 29. doi: 10.1002/hed.26479.
    PubMed     Abstract available


  452. LIU YP, Wang SL, Zou X, You R, et al
    Transcervical endoscopic retropharyngeal lymph node (RPLN) dissection in nasopharyngeal carcinoma with RPLN recurrence.
    Head Neck. 2020 Sep 28. doi: 10.1002/hed.26459.
    PubMed     Abstract available


  453. MHASKAR R, Caputo MP, Mifsud MJ
    Reply to Letter to the Editor regarding "Diabetes mellitus in major head and neck cancer surgery: Systematic review and meta-analysis".
    Head Neck. 2020 Sep 23. doi: 10.1002/hed.26446.
    PubMed    


  454. HUANG GJ, Kong XY
    Diabetes mellitus in major head and neck cancer surgery.
    Head Neck. 2020 Sep 23. doi: 10.1002/hed.26451.
    PubMed    


  455. KRIPLANI A, Lavery JA, Mishra A, Korenstein D, et al
    Trends in chronic opioid therapy among survivors of head and neck cancer.
    Head Neck. 2020 Sep 22. doi: 10.1002/hed.26478.
    PubMed     Abstract available


  456. LIAO AH, Lin WT, Chen HK, Shih CP, et al
    Synergistic effects of combined treatment with ultrasound-mediated cisplatin-loaded microbubbles and atorvastatin on head and neck cancer.
    Head Neck. 2020 Sep 21. doi: 10.1002/hed.26445.
    PubMed     Abstract available


  457. LUO Y, Ma J, Liu F, Guo J, et al
    Diagnostic value of exosomal circMYC in radioresistant nasopharyngeal carcinoma.
    Head Neck. 2020 Sep 18. doi: 10.1002/hed.26441.
    PubMed     Abstract available


  458. ZOLKIND P, Lee JJ, Jackson RS, Pipkorn P, et al
    Untreated head and neck cancer: Natural history and associated factors.
    Head Neck. 2020 Sep 11. doi: 10.1002/hed.26460.
    PubMed     Abstract available


  459. RIJO-CEDENO J, Mucientes J, Alvarez O, Royuela A, et al
    Metabolic tumor volume and total lesion glycolysis as prognostic factors in head and neck cancer: Systematic review and meta-analysis.
    Head Neck. 2020 Sep 11. doi: 10.1002/hed.26461.
    PubMed     Abstract available


  460. TAE K
    Reply to Letter to the Editor: Transoral robotic selective neck dissection for papillary thyroid carcinoma: Is it appropriate?
    Head Neck. 2020 Sep 5. doi: 10.1002/hed.26449.
    PubMed    


  461. PICCIN O, D'Alessio P, Cavicchi O
    Transoral robotic selective neck dissection for papillary thyroid carcinoma: Is it appropriate?
    Head Neck. 2020 Sep 5. doi: 10.1002/hed.26447.
    PubMed    


  462. HUANG GJ, Yang BB
    Identification of genes associated with cancer stem cell characteristics in head and neck squamous cell carcinoma.
    Head Neck. 2020 Sep 1. doi: 10.1002/hed.26388.
    PubMed    


  463. ZHU X
    Reply to Letter to the Editor regarding "Identification of genes associated with cancer stem cell characteristics in head and neck squamous cell carcinoma through co-expression network analysis".
    Head Neck. 2020 Sep 1. doi: 10.1002/hed.26390.
    PubMed    


  464. PANUGANTI A, Kaul P, Singh MP, Garg PK, et al
    Patient participation in decision making-undisputed fact.
    Head Neck. 2020;42:2242-2243.
    PubMed    


  465. BAGADIA RK, Kudpaje AS, Rao VUS
    From compartmental to anatomically based circumferential resection-Is the reversal of trend justified?
    Head Neck. 2020;42:2764-2765.
    PubMed    


  466. CALABRESE L, Pietrobon G, Fazio E, Accorona R, et al
    Reply to "From compartmental to anatomically-based circumferential resection-Is the trend reversal of justified?"
    Head Neck. 2020;42:2766-2767.
    PubMed    


    August 2020
  467. LOPEZ EM, Tanner AM, Du E, Patel SN, et al
    Decline in circulating viral and human tumor markers after resection of head and neck carcinoma.
    Head Neck. 2020 Aug 28. doi: 10.1002/hed.26444.
    PubMed     Abstract available


  468. SU L, Lin Q, Li R, Hua Y, et al
    Prognostic value of nutritional impairment on treatment-related toxicity and survival in patients with nasopharyngeal carcinoma taking normal nutrition before radiotherapy.
    Head Neck. 2020 Aug 27. doi: 10.1002/hed.26426.
    PubMed     Abstract available


  469. CRAWFORD KL, Jafari A, Qualliotine JR, Stuart E, et al
    Elective neck dissection for T3/T4 cN0 sinonasal squamous cell carcinoma.
    Head Neck. 2020 Aug 24. doi: 10.1002/hed.26418.
    PubMed     Abstract available


  470. ZHI-JUN X, Yue-Xiao L, Bo-Yu G, Ya-Tin J, et al
    Are contralateral submental artery perforator flaps feasible for the reconstruction of postoperative defects of oral cancer?
    Head Neck. 2020 Aug 22. doi: 10.1002/hed.26422.
    PubMed     Abstract available


  471. DOUGLAS CM, Jethwa AR, Hasan W, Liu A, et al
    Long-term survival of head and neck squamous cell carcinoma after bone marrow transplant.
    Head Neck. 2020 Aug 21. doi: 10.1002/hed.26402.
    PubMed     Abstract available


  472. STANISZ I, Janik S, Grasl MC, Erovic BM, et al
    Panendoscopy during follow-up in laryngeal carcinoma patients after radiotherapy.
    Head Neck. 2020 Aug 21. doi: 10.1002/hed.26433.
    PubMed     Abstract available


  473. ARBAB M, Chen YH, Criscitiello S, Glass J, et al
    Patient reported outcomes in patients with head and neck cancer treated with concurrent chemoradiation with weekly versus bolus cisplatin.
    Head Neck. 2020 Aug 19. doi: 10.1002/hed.26432.
    PubMed     Abstract available


  474. MALIK A, Nair S
    Reply to Letter to the Editor regarding "Soft tissue deposits in oral cancers".
    Head Neck. 2020 Aug 13. doi: 10.1002/hed.26412.
    PubMed    


  475. NABUURS CH, Kievit W, Labbe N, Leemans CR, et al
    Evaluation of the modified Pittsburgh classification for predicting the disease-free survival outcome of squamous cell carcinoma of the external auditory canal.
    Head Neck. 2020 Aug 13. doi: 10.1002/hed.26424.
    PubMed     Abstract available


  476. SMITH DK, Cmelak A, Niermann K, Ghiam M, et al
    Preventive use of gabapentin to decrease pain and systemic symptoms in patients with head and neck cancer undergoing chemoradiation.
    Head Neck. 2020 Aug 7. doi: 10.1002/hed.26407.
    PubMed     Abstract available


  477. URABE M, Ueno M, Udagawa H
    Incidental identification of cervical nodal metastases from papillary thyroid carcinoma: Experiences related to esophageal cancer surgery.
    Head Neck. 2020 Aug 6. doi: 10.1002/hed.26392.
    PubMed    


  478. SHAH J
    Reply to the Letter to the Editor regarding "Significance and management of incidentally diagnosed metastatic papillary thyroid carcinoma in cervical lymph nodes in neck dissection specimens".
    Head Neck. 2020 Aug 6. doi: 10.1002/hed.26391.
    PubMed    


  479. DU C, Tao Y
    Response to comments HN-20-1003 "Induction chemotherapy followed by radiotherapy for N3 head and neck squamous cell carcinoma: useful treatment option with a caveat".
    Head Neck. 2020 Aug 6. doi: 10.1002/hed.26408.
    PubMed    


  480. CHAKRABORTY A, Thiagarajan S
    Induction chemotherapy followed by radiotherapy for N3 head and neck squamous cell carcinoma-Useful treatment option with a caveat.
    Head Neck. 2020 Aug 6. doi: 10.1002/hed.26413.
    PubMed    


  481. KRAFT S, Gadkaree SK, Deschler DG, Lin DT, et al
    Programmed cell death ligand-1 and cytotoxic T cell infiltrates in metastatic cutaneous squamous cell carcinoma of the head and neck.
    Head Neck. 2020 Aug 1. doi: 10.1002/hed.26370.
    PubMed     Abstract available


  482. BONOMO P, Talamonti C, Caini S
    Reply to Yamazaki et al (HED-19-525.R1).
    Head Neck. 2020;42:2219-2220.
    PubMed    


  483. YAMAZAKI H, Suzuki G, Takenaka T, Yoshida K, et al
    Is there clinical meaningful threshold in dose volume analysis between grade 0-2 and 3-4 radiation dermatitis?
    Head Neck. 2020;42:2217-2218.
    PubMed    


  484. SABOUR S
    Cytology in parotid Warthin's tumors: Methodological issues on diagnostic value to avoid misinterpretation.
    Head Neck. 2020;42:2213-2214.
    PubMed    


  485. BORSETTO D, Fussey JM, Cazzador D, Smith J, et al
    The diagnostic value of cytology in parotid Warthin's tumors: International multicenter series.
    Head Neck. 2020;42:2215-2216.
    PubMed    


    July 2020
  486. JEANS C, Brown B, Ward EC, Vertigan AE, et al
    Comparing the prevalence, location, and severity of head and neck lymphedema after postoperative radiotherapy for oral cavity cancers and definitive chemoradiotherapy for oropharyngeal, laryngeal, and hypopharyngeal cancers.
    Head Neck. 2020 Jul 31. doi: 10.1002/hed.26394.
    PubMed     Abstract available


  487. KARAN N, Siddiqui S, Sharma KS, Pantvaidya GH, et al
    Evaluation and validation of Physiological and Operative Severity Score for the enumeration of mortality and morbidity and Portsmouth-POSSUM scores in predicting morbidity and mortality in patients undergoing head and neck cancer surgeries.
    Head Neck. 2020 Jul 27. doi: 10.1002/hed.26354.
    PubMed     Abstract available


  488. GOGINENI E, Rana Z, Vempati P, Karten J, et al
    Stereotactic body radiotherapy as primary treatment for elderly and medically inoperable patients with head and neck cancer.
    Head Neck. 2020 Jul 21. doi: 10.1002/hed.26342.
    PubMed     Abstract available


  489. DEUTSCH FT, Khoury SJ, Sunwoo JB, Elliott MS, et al
    Application of salivary noncoding microRNAs for the diagnosis of oral cancers.
    Head Neck. 2020 Jul 20. doi: 10.1002/hed.26348.
    PubMed     Abstract available


  490. LINDEGAARD AM, von Buchwald C, Rasmussen JH, Specht L, et al
    Outcome in patients with isolated regional recurrence after primary radiotherapy for head and neck cancer.
    Head Neck. 2020 Jul 18. doi: 10.1002/hed.26361.
    PubMed     Abstract available


  491. UEKI Y, Takahashi T, Ota H, Shodo R, et al
    Role of programmed death-ligand 1 in predicting the treatment outcome of salvage chemotherapy after nivolumab in recurrent/metastatic head and neck squamous cell carcinoma.
    Head Neck. 2020 Jul 16. doi: 10.1002/hed.26374.
    PubMed     Abstract available


  492. DAGAN O, Moore A, Nachlon Y, Alkan U, et al
    Induction chemotherapy for locally advanced laryngeal and hypopharyngeal cancer: Single institution experience.
    Head Neck. 2020 Jul 16. doi: 10.1002/hed.26353.
    PubMed     Abstract available


  493. CAPUTO MP, Shabani S, Mhaskar R, McMullen C, et al
    Diabetes mellitus in major head and neck cancer surgery: Systematic review and meta-analysis.
    Head Neck. 2020 Jul 11. doi: 10.1002/hed.26349.
    PubMed     Abstract available


  494. LE ROUX MK, Graillon N, Guyot L, Taieb D, et al
    Salivary side effects after radioiodine treatment for differentiated papillary thyroid carcinoma: Long-term study.
    Head Neck. 2020 Jul 11. doi: 10.1002/hed.26359.
    PubMed     Abstract available


  495. TAE K, Kim KH
    Transoral robotic selective neck dissection for papillary thyroid carcinoma: Dissection of Levels III and IV.
    Head Neck. 2020 Jul 7. doi: 10.1002/hed.26379.
    PubMed     Abstract available


  496. HOLMES BJ, von Eyben R, Attardi LD, Kong CS, et al
    Pilot study of loss of the p53/p63 target gene PERP at the surgical margin as a potential predictor of local relapse in head and neck squamous cell carcinoma.
    Head Neck. 2020 Jul 7. doi: 10.1002/hed.26358.
    PubMed     Abstract available


  497. MUSORO JZ, Coens C, Singer S, Tribius S, et al
    Minimally important differences for interpreting European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 scores in patients with head and neck cancer.
    Head Neck. 2020 Jul 6. doi: 10.1002/hed.26363.
    PubMed     Abstract available


  498. FARQUHAR DR, Lenze NR, Masood MM, Divaris K, et al
    Access to preventive care services and stage at diagnosis in head and neck cancer.
    Head Neck. 2020 Jul 3. doi: 10.1002/hed.26326.
    PubMed     Abstract available


  499. LANDIN D, Ahrlund-Richter A, Mirzaie L, Mints M, et al
    Immune related proteins and tumor infiltrating CD8+ lymphocytes in hypopharyngeal cancer in relation to human papillomavirus (HPV) and clinical outcome.
    Head Neck. 2020 Jul 1. doi: 10.1002/hed.26364.
    PubMed     Abstract available


  500. GORDIN EA, Day A, Stankova L, Heitman E, et al
    Care in the time of coronavirus: Ethical considerations in head and neck oncology.
    Head Neck. 2020;42:1519-1525.
    PubMed     Abstract available


  501. GALLO O, Locatello LG
    Laser-assisted head and neck surgery in the COVID-19 pandemic: Controversial evidence and precautions.
    Head Neck. 2020;42:1533-1534.
    PubMed    


  502. MORRISON DR, Gentile C, McCammon S, Buczek E, et al
    Head and neck oncologic surgery in the COVID-19 pandemic: Our experience in a deep south tertiary care center.
    Head Neck. 2020;42:1471-1476.
    PubMed     Abstract available


  503. SHANTI RM, Stoopler ET, Weinstein GS, Newman JG, et al
    Considerations in the evaluation and management of oral potentially malignant disorders during the COVID-19 pandemic.
    Head Neck. 2020;42:1497-1502.
    PubMed     Abstract available


  504. TURRI-ZANONI M, Battaglia P, Karligkiotis A, Locatelli D, et al
    Managing care for patients with sinonasal and anterior skull base cancers during the COVID-19 pandemic.
    Head Neck. 2020;42:1503-1506.
    PubMed     Abstract available


  505. GIVI B, Moore MG, Bewley AF, Coffey CS, et al
    Advanced head and neck surgery training during the COVID-19 pandemic.
    Head Neck. 2020;42:1411-1417.
    PubMed     Abstract available


  506. HUANG VW, Imam SA, Nguyen SA
    Head and neck survivorship care in the times of the SARS-CoV-2 pandemic.
    Head Neck. 2020;42:1664-1667.
    PubMed     Abstract available


  507. BRODY RM, Albergotti WG, Shimunov D, Nicolli E, et al
    Changes in head and neck oncologic practice during the COVID-19 pandemic.
    Head Neck. 2020;42:1448-1453.
    PubMed     Abstract available


    June 2020
  508. FERRANDINO RM, Roof S, Garneau J, Haidar Y, et al
    Neutrophil-to-lymphocyte ratio as a prognostic indicator for overall and cancer-specific survival in squamous cell carcinoma of the head and neck.
    Head Neck. 2020 Jun 27. doi: 10.1002/hed.26329.
    PubMed     Abstract available


  509. LEON X, Neumann E, Gutierrez A, Garcia J, et al
    Weighted lymph node ratio: New tool in the assessment of postoperative staging of the neck dissection in HPV-negative head and neck squamous cell carcinoma patients.
    Head Neck. 2020 Jun 26. doi: 10.1002/hed.26340.
    PubMed     Abstract available


  510. WEINSTEIN GS, Cohen R, Lin A, O'Malley BW Jr, et al
    Penn Medicine Head and Neck Cancer Service Line COVID-19 management guidelines.
    Head Neck. 2020 Jun 25. doi: 10.1002/hed.26318.
    PubMed     Abstract available


  511. YEN CJ, Kiyota N, Hanai N, Takahashi S, et al
    Two-year follow-up of a randomized phase III clinical trial of nivolumab vs. the investigator's choice of therapy in the Asian population for recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141).
    Head Neck. 2020 Jun 24. doi: 10.1002/hed.26331.
    PubMed     Abstract available


  512. HOLCOMB AJ, Perryman M, Goodwin S, Penn J, et al
    Pathology protocol increases lymph node yield in neck dissection for oral cavity squamous cell carcinoma.
    Head Neck. 2020 Jun 24. doi: 10.1002/hed.26343.
    PubMed     Abstract available


  513. GRABOYES E, Cramer J, Balakrishnan K, Cognetti DM, et al
    COVID-19 pandemic and health care disparities in head and neck cancer: Scanning the horizon.
    Head Neck. 2020 Jun 20. doi: 10.1002/hed.26345.
    PubMed     Abstract available


  514. OH J, Liu A, Tran E, Berthelet E, et al
    Association between nutritional risk index and outcomes for head and neck cancer patients receiving concurrent chemo-radiotherapy.
    Head Neck. 2020 Jun 20. doi: 10.1002/hed.26315.
    PubMed     Abstract available


  515. VAN DER GEER SJ, van Rijn PV, Roodenburg JLN, Dijkstra PU, et al
    Prognostic factors associated with a restricted mouth opening (trismus) in patients with head and neck cancer: Systematic review.
    Head Neck. 2020 Jun 18. doi: 10.1002/hed.26327.
    PubMed     Abstract available


  516. ALTERIO D, Volpe S, Marvaso G, Turturici I, et al
    Head and neck cancer radiotherapy amid COVID-19 pandemic: Report from Milan, Italy.
    Head Neck. 2020 Jun 18. doi: 10.1002/hed.26319.
    PubMed     Abstract available



  517. Corrigendum to "Evaluation of oncologic outcomes in head and neck cancer patients > 80 years old based on adherence to NCCN guideline for postoperative adjuvant treatment" [Head and Neck, 2019:41(12):4128-4135].
    Head Neck. 2020 Jun 17. doi: 10.1002/hed.26309.
    PubMed    


  518. CHOI Y, Ahn KJ, Jang J, Shin NY, et al
    Prognostic value of computed tomography-based volumetric body composition analysis in patients with head and neck cancer: Feasibility study.
    Head Neck. 2020 Jun 16. doi: 10.1002/hed.26310.
    PubMed     Abstract available


  519. PANNU JS, Simpson MC, Donovan CL, Adjei Boakye E, et al
    Sociodemographic correlates of head and neck cancer survival among patients with metastatic disease.
    Head Neck. 2020 Jun 16. doi: 10.1002/hed.26284.
    PubMed     Abstract available


  520. HALL JA, Rusten M, Abughazaleh RD, Wuertz B, et al
    Effects of PPAR-gamma agonists on oral cancer cell lines: Potential horizons for chemopreventives and adjunctive therapies.
    Head Neck. 2020 Jun 9. doi: 10.1002/hed.26286.
    PubMed     Abstract available


  521. KEJNER AE, Li H, Li EY, Porterfield JZ, et al
    Reply to Letter to the Editor regarding "Treatment modality and outcomes in larynx cancer patients: A sex-based evaluation".
    Head Neck. 2020 Jun 8. doi: 10.1002/hed.26156.
    PubMed    


  522. HUANG GJ, Huang ZH
    Treatment modality and outcomes in larynx cancer patients.
    Head Neck. 2020 Jun 8. doi: 10.1002/hed.26157.
    PubMed    


  523. YAN F, Byun YJ, Nguyen SA, Stalcup ST, et al
    Predictive value of computed tomography in identifying extranodal extension in human papillomavirus-positive versus human papillomavirus-negative head and neck cancer.
    Head Neck. 2020 Jun 2. doi: 10.1002/hed.26281.
    PubMed     Abstract available


  524. KAWASHITA Y, Morimoto S, Tashiro K, Soutome S, et al
    Risk factors associated with the development of aspiration pneumonia in patients receiving radiotherapy for head and neck cancer: retrospective study.
    Head Neck. 2020 Jun 1. doi: 10.1002/hed.26314.
    PubMed     Abstract available


  525. FRIED J, Etter JL, Stenzel AE, Joseph JM, et al
    Physical inactivity and head and neck cancer mortality.
    Head Neck. 2020 Jun 1. doi: 10.1002/hed.26283.
    PubMed     Abstract available


  526. DAY AT, Dahlstrom KR, Lee R, Karam-Hage M, et al
    Impact of a tobacco treatment program on abstinence and survival rates among current smokers with head and neck squamous cell carcinoma.
    Head Neck. 2020 Jun 1. doi: 10.1002/hed.26268.
    PubMed     Abstract available


  527. GALLI J, Settimi S, Tricarico L, Almadori G, et al
    Clinical and surgical management of patients with head and neck cancer in a COVID-19 dedicated center in Italy.
    Head Neck. 2020 Jun 1. doi: 10.1002/hed.26263.
    PubMed     Abstract available


  528. KIONG KL, Guo T, Yao CMKL, Gross ND, et al
    Changing practice patterns in head and neck oncologic surgery in the early COVID-19 era.
    Head Neck. 2020;42:1179-1186.
    PubMed     Abstract available


  529. QUALLIOTINE JR, Orosco RK
    Self-removing passive drain to facilitate postoperative care via telehealth during the COVID-19 pandemic.
    Head Neck. 2020;42:1305-1307.
    PubMed     Abstract available


  530. MANIAKAS A, Jozaghi Y, Zafereo ME, Sturgis EM, et al
    Head and neck surgical oncology in the time of a pandemic: Subsite-specific triage guidelines during the COVID-19 pandemic.
    Head Neck. 2020;42:1194-1201.
    PubMed     Abstract available


  531. WU V, Noel CW, Forner D, Zhang ZJ, et al
    Considerations for head and neck oncology practices during the coronavirus disease 2019 (COVID-19) pandemic: Wuhan and Toronto experience.
    Head Neck. 2020;42:1202-1208.
    PubMed     Abstract available


  532. SINGH AG, Chaturvedi P
    Tobacco use and vaping in the COVID-19 era.
    Head Neck. 2020;42:1240-1242.
    PubMed     Abstract available


  533. RANASINGHE V, Mady LJ, Kim S, Ferris RL, et al
    Major head and neck reconstruction during the COVID-19 pandemic: The University of Pittsburgh approach.
    Head Neck. 2020;42:1243-1247.
    PubMed     Abstract available


  534. SHAH JP
    The impact of COVID-19 on Head and Neck surgery, education, and training.
    Head Neck. 2020;42:1344-1347.
    PubMed    


  535. BADDOUR K, Kudrick LD, Neopaney A, Sabik LM, et al
    Potential impact of the COVID-19 pandemic on financial toxicity in cancer survivors.
    Head Neck. 2020;42:1332-1338.
    PubMed     Abstract available


  536. PATEL RJ, Kejner A, McMullen C
    Early institutional head and neck oncologic and microvascular surgery practice patterns across the United States during the SARS-CoV-2 (COVID19) pandemic.
    Head Neck. 2020;42:1168-1172.
    PubMed     Abstract available


  537. TOPF MC, Shenson JA, Holsinger FC, Wald SH, et al
    Framework for prioritizing head and neck surgery during the COVID-19 pandemic.
    Head Neck. 2020;42:1159-1167.
    PubMed     Abstract available


  538. PRASAD A, Carey RM, Rajasekaran K
    Head and neck virtual medicine in a pandemic era: Lessons from COVID-19.
    Head Neck. 2020;42:1308-1309.
    PubMed     Abstract available


  539. CAI YC, Wang W, Li C, Zeng DF, et al
    Treating head and neck tumors during the SARS-CoV-2 epidemic, 2019 to 2020: Sichuan Cancer Hospital.
    Head Neck. 2020;42:1153-1158.
    PubMed     Abstract available


    May 2020
  540. MROUEH R, Tanskanen T, Haapaniemi A, Salo T, et al
    Familial cancer risk in family members and spouses of patients with early-onset head and neck cancer.
    Head Neck. 2020 May 30. doi: 10.1002/hed.26282.
    PubMed     Abstract available


  541. YAN F, Rauscher E, Hollinger A, Caputo MA, et al
    The role of head and neck cancer advocacy organizations during the COVID-19 pandemic.
    Head Neck. 2020 May 29. doi: 10.1002/hed.26287.
    PubMed     Abstract available


  542. PEI S, Chen L, Yang Y, Zhu X, et al
    Identification of genes associated with cancer stem cell characteristics in head and neck squamous cell carcinoma through co-expression network analysis.
    Head Neck. 2020 May 27. doi: 10.1002/hed.26266.
    PubMed     Abstract available


  543. PAGEDAR NA, Kendell N, Christensen AJ, Thomsen TA, et al
    Head and neck cancer survivorship from the patient perspective.
    Head Neck. 2020 May 23. doi: 10.1002/hed.26265.
    PubMed     Abstract available


  544. FOKI E, Gangl K, Kranebitter V, Niederberger-Leppin V, et al
    Early effects of cigarette smoke extract on human oral keratinocytes and carcinogenesis in head and neck squamous cell carcinoma.
    Head Neck. 2020 May 21. doi: 10.1002/hed.26247.
    PubMed     Abstract available


  545. LEE J, Shin IS, Kim WC, Yoon WS, et al
    Reirradiation with intensity-modulated radiation therapy for recurrent or secondary head and neck cancer: Meta-analysis and systematic review.
    Head Neck. 2020 May 21. doi: 10.1002/hed.26264.
    PubMed     Abstract available


  546. NILSEN ML, Clump DA 2nd, Kubik M, Losego K, et al
    Prevision of multidisciplinary head and neck cancer survivorship care during the 2019 novel coronavirus pandemic.
    Head Neck. 2020 May 18. doi: 10.1002/hed.26256.
    PubMed     Abstract available


  547. VERMA N, Patel S, Osborn V, McBride S, et al
    Prognostic significance of human papillomavirus and Epstein-Bar virus in nasopharyngeal carcinoma.
    Head Neck. 2020 May 16. doi: 10.1002/hed.26245.
    PubMed     Abstract available


  548. BOWMAN R, Crosby DL, Sharma A
    Surge after the surge: Anticipating the increased volume and needs of patients with head and neck cancer after the peak in COVID-19.
    Head Neck. 2020 May 16. doi: 10.1002/hed.26260.
    PubMed     Abstract available


  549. QIN T, Koneva LA, Liu Y, Zhang Y, et al
    Significant association between host transcriptome-derived HPV oncogene E6* influence score and carcinogenic pathways, tumor size, and survival in head and neck cancer.
    Head Neck. 2020 May 14. doi: 10.1002/hed.26244.
    PubMed     Abstract available


  550. CHANG CF, Ei-Sayed IH, George JR, Heaton CM, et al
    Modified technique of submandibular gland transfer followed by intensity modulated radiotherapy to reduce xerostomia in head and neck cancer patients.
    Head Neck. 2020 May 13. doi: 10.1002/hed.26249.
    PubMed     Abstract available


  551. PALERI V, Hardman J, Tikka T, Bradley P, et al
    Rapid implementation of an evidence-based remote triaging system for assessment of suspected head and neck cancer referrals and patients on follow up after treatment during the COVID-19 pandemic: A model for international collaboration.
    Head Neck. 2020 May 6. doi: 10.1002/hed.26219.
    PubMed     Abstract available


  552. KIM DH, Kim Y, Kim SW, Hwang SH, et al
    Use of narrowband imaging for the diagnosis and screening of laryngeal cancer: A systematic review and meta-analysis.
    Head Neck. 2020 May 4. doi: 10.1002/hed.26186.
    PubMed     Abstract available


  553. CIVANTOS FJ, Leibowitz JM, Arnold DJ, Stubbs VC, et al
    Ethical Surgical Triage of Head and Neck Cancer Patients during the COVID-19 Pandemic.
    Head Neck. 2020 May 1. doi: 10.1002/hed.26229.
    PubMed     Abstract available


  554. GUPTA A, Arora V, Nair D, Agrawal N, et al
    Status and strategies for the management of head and neck cancer during COVID-19 pandemic: Indian Scenario.
    Head Neck. 2020 May 1. doi: 10.1002/hed.26227.
    PubMed     Abstract available


  555. LEE AK, FRCSEd RHC, FRCSEd EHL, Cheng HK, et al
    Mitigation of Head and Neck Cancer Service Disruption During COVID-19 in Hong Kong Through Telehealth and Multi-institution Collaboration.
    Head Neck. 2020 May 1. doi: 10.1002/hed.26226.
    PubMed     Abstract available


    April 2020
  556. MASSA ST, Pipkorn P, Jackson RS, Zevallos JP, et al
    Access to a regular medical provider among head and neck cancer survivors.
    Head Neck. 2020 Apr 30. doi: 10.1002/hed.26182.
    PubMed     Abstract available


  557. KU PK, Holsinger FC, Chan JY, Yeung ZC, et al
    Management of Dysphagia in The Head and Neck Cancer Patient during COVID-19 Pandemic: A Practical Strategy.
    Head Neck. 2020 Apr 29. doi: 10.1002/hed.26224.
    PubMed     Abstract available


  558. PRASAD A, Brewster R, Newman JG, Rajasekaran K, et al
    Optimizing your telemedicine visit during the COVID-19 pandemic: Practice guidelines for patients with head and neck cancer.
    Head Neck. 2020 Apr 28. doi: 10.1002/hed.26197.
    PubMed     Abstract available


  559. SHARMA A, Crosby DL
    Special considerations for elderly patients with head and neck cancer during the COVID-19 pandemic.
    Head Neck. 2020 Apr 28. doi: 10.1002/hed.26216.
    PubMed     Abstract available


  560. SILVERMAN DA, Lin C, Tamaki A, Puram SV, et al
    Respiratory and pulmonary complications in head and neck cancer patients: Evidence-based review for the COVID-19 era.
    Head Neck. 2020 Apr 28. doi: 10.1002/hed.26217.
    PubMed     Abstract available


  561. CHOW VLY, Chan JYW, Ho VWY, Lee GCC, et al
    Conservation of personal protective equipment for head and neck cancer surgery during COVID-19 pandemic.
    Head Neck. 2020 Apr 28. doi: 10.1002/hed.26215.
    PubMed     Abstract available


  562. SINGH AG, Deodhar J, Chaturvedi P
    Navigating the impact of COVID-19 on palliative care for head and neck cancer.
    Head Neck. 2020 Apr 27. doi: 10.1002/hed.26211.
    PubMed     Abstract available


  563. YAN F, Nguyen SA
    Head and neck cancer: A high-risk population for COVID-19.
    Head Neck. 2020 Apr 27. doi: 10.1002/hed.26209.
    PubMed    


  564. NOEL CW, Stephens RF, Su JS, Xu W, et al
    Mapping the EORTC QLQ-C30 and QLQ-H&N35, onto EQ-5D-5L and HUI-3 indices in patients with head and neck cancer.
    Head Neck. 2020 Apr 25. doi: 10.1002/hed.26181.
    PubMed     Abstract available


  565. BHATTACHARJEE A, Patil VM, Dikshit R, Prabhash K, et al
    Should we wait or not? The preferable option for patients with stage IV oral cancer in COVID-19 pandemic.
    Head Neck. 2020 Apr 24. doi: 10.1002/hed.26196.
    PubMed     Abstract available


  566. SHUMAN AG, Campbell BH
    An Ethical Framework for Head and Neck Cancer Care Impacted by COVID-19.
    Head Neck. 2020 Apr 24. doi: 10.1002/hed.26193.
    PubMed     Abstract available


  567. WANG L, Cao J, Wang X, Lin E, et al
    Proton and photon radiosensitization effects of niraparib, a PARP-1/-2 inhibitor, on human head and neck cancer cells.
    Head Neck. 2020 Apr 23. doi: 10.1002/hed.26155.
    PubMed     Abstract available


  568. DAI LB, Yu Q, Zhou SH, Bao YY, et al
    Effect of combination of curcumin and GLUT-1 AS-ODN on radiosensitivity of laryngeal carcinoma through regulating autophagy.
    Head Neck. 2020 Apr 21. doi: 10.1002/hed.26180.
    PubMed     Abstract available


  569. KLIGERMAN MP, Vukkadala N, Tsang RKY, Sunwoo JB, et al
    Managing the Head and Neck Cancer Patient with Tracheostomy or Laryngectomy During the COVID-19 Pandemic.
    Head Neck. 2020 Apr 16. doi: 10.1002/hed.26171.
    PubMed    


  570. BOAKYE EA, Jenkins W, Sharma A
    Disproportionate impact of COVID-19 Pandemic on Head and Neck Cancer Survivors.
    Head Neck. 2020 Apr 16. doi: 10.1002/hed.26170.
    PubMed    


  571. CIVANTOS AM, Carey RM, Lichtenstein GR, Lukens JN, et al
    Care of Immunocompromised Patients with Head and Neck Cancer During the COVID-19 Pandemic: Two Challenging and Informative Clinical Cases.
    Head Neck. 2020 Apr 16. doi: 10.1002/hed.26165.
    PubMed     Abstract available


  572. RASSEKH CH, Jenks CM, Ochroch EA, Douglas JE, et al
    Management of the difficult airway in the COVID-19 pandemic: Illustrative complex head and neck cancer scenario.
    Head Neck. 2020 Apr 16. doi: 10.1002/hed.26175.
    PubMed     Abstract available


  573. LEE MY, Allen CT
    Mechanisms of resistance to T cell-based immunotherapy in head and neck cancer.
    Head Neck. 2020 Apr 10. doi: 10.1002/hed.26158.
    PubMed     Abstract available


    March 2020
  574. VENGALOOR THOMAS T, Packianathan S, Bhanat E, Albert A, et al
    Oligometastatic head and neck cancer: Comprehensive review.
    Head Neck. 2020 Mar 27. doi: 10.1002/hed.26144.
    PubMed     Abstract available


  575. TSUKUURA R, Kageyama T, Sakai H, Fuse Y, et al
    Possible risk of iatrogenic lymphedema after harvest of posterior tibial artery perforator flap.
    Head Neck. 2020;42:585.
    PubMed    


    February 2020
  576. ILAPAKRUTY B, Rao VUS
    Is tailored management better than salvage in laryngeal squamous cell carcinomas.
    Head Neck. 2020;42:357.
    PubMed    


  577. MIMICA X, Hanson M, Cohen MA
    Reply to the letter of the editor: Is tailored management better than salvage in laryngeal squamous cell carcinomas?
    Head Neck. 2020;42:358-359.
    PubMed    


    January 2020
  578. ILMARINEN T, Keski-Santti HT, Markkanen-Leppanen ML, Haapaniemi A, et al
    Reply to "Do not de-escalate oncology care in oropharyngeal cancer routinely".
    Head Neck. 2020;42:145-146.
    PubMed    


  579. SZTURZ P, Vermorken JB
    Do not de-escalate oncology care in oropharyngeal cancer routinely.
    Head Neck. 2020;42:143-144.
    PubMed    


    September 2019
  580. BALAGUER M, Pommee T, Farinas J, Pinquier J, et al
    Effects of oral and oropharyngeal cancer on speech intelligibility using acoustic analysis: Systematic review.
    Head Neck. 2019 Sep 30. doi: 10.1002/hed.25949.
    PubMed     Abstract available


    March 2019
  581. MAEBAYASHI T, Ishibashi N, Aizawa T, Sakaguchi M, et al
    Effectiveness of chemoradiotherapy for radiation-induced bilateral external auditory canal cancer: A case report and literature review.
    Head Neck. 2019 Mar 4. doi: 10.1002/hed.25728.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: